WO2017152655A1 - Traditional chinese medicine preparation for treating qi and blood deficiency-type generalized anxiety disorder - Google Patents

Traditional chinese medicine preparation for treating qi and blood deficiency-type generalized anxiety disorder Download PDF

Info

Publication number
WO2017152655A1
WO2017152655A1 PCT/CN2016/106765 CN2016106765W WO2017152655A1 WO 2017152655 A1 WO2017152655 A1 WO 2017152655A1 CN 2016106765 W CN2016106765 W CN 2016106765W WO 2017152655 A1 WO2017152655 A1 WO 2017152655A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
parts
chinese medicine
traditional chinese
medicine preparation
Prior art date
Application number
PCT/CN2016/106765
Other languages
French (fr)
Chinese (zh)
Inventor
王平平
Original Assignee
王平平
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 王平平 filed Critical 王平平
Publication of WO2017152655A1 publication Critical patent/WO2017152655A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/69Polygalaceae (Milkwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884Arisaema, e.g. Jack in the pulpit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888Pinellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Definitions

  • the present invention relates to the technical field of traditional Chinese medicine, and in particular to a traditional Chinese medicine preparation for treating a syndrome of generalized anxiety disorder.
  • GAD Generalized alexiety dis-order
  • Anxious physical changes include high muscle tension, rapid breathing, high blood pressure, sweating, dizziness, chest tightness, palpitations, tremors, urgency, frequent urination, vomiting, bloating, diarrhea, etc.
  • psychological changes are excitable, and thoughts are focused on Some things, irritability and emotions, changes in thinking style; behavioral changes are too high level of alertness, dealing with things is not easy to concentrate, loss of interest in things in daily life, etc., patients feel unbearable and unable to relieve and feel pain.
  • the pathogenesis and treatment have been thoroughly studied.
  • the common cause of anxiety is psychological conflict.
  • the pathogenesis may be an increase in norepinephrine (NE) activity, 5-hydroxytryptamine (5-HT) function and dopamine dysfunction.
  • NE norepinephrine
  • 5-HT 5-hydroxytryptamine
  • Modern medical treatment of this disease is mainly in the two aspects of drug intervention and psychological regulation.
  • Drug treatment includes tricyclic antidepressants (TCAs), reversible and irreversible monoamine oxidase inhibitors (MA015), and high-efficiency benzodiazepines (BZDs).
  • TCAs tricyclic antidepressants
  • MA015 reversible and irreversible monoamine oxidase inhibitors
  • BZDs high-efficiency benzodiazepines
  • Drugs, selective serotonin reuptake blockers (SSRIs), etc. can achieve certain therapeutic effects, but have the disadvantages of high addiction, strong drug resistance, and many side
  • Anxiety is a category of emotional illness in the motherland medicine. Although there is no disease name, it is associated with depression, despicableness, and porpoise. Lily diseases are all related. Modern Chinese medicine believes that the occurrence of anxiety disorders is mostly due to emotional stagnation, liver qi stagnation, or stagnation of fire, heart fire, restlessness, lack of blood, liver qi stagnation, kidney essence Insufficient, hepatobiliary deficiency, and treatment Should be based on Shugan Liqi, taking care of the heart, liver, kidney three organs. In recent years, research on the treatment of anxiety disorders with Chinese medicine has gradually increased. The results show that Chinese medicine has a good effect on the treatment of this disease, which significantly reduces side effects and drug dependence.
  • liver qi stagnation, blood flow is not smooth, long-term sputum, liver stagnation against the spleen, spleen lost health, qi and blood biochemical sources, qi stagnation and blood stasis is more, and can cause blood without The heart is lost to the Lord, and the disease can be entangled for a long time, thus making the disease difficult to heal.
  • liver gas is not sparse, liver qi stagnation for a long time, qi stagnation, can appear irritable, chest tightness, bloating, headache
  • mouth bitter, noisy pantothenic acid will be urinary yellow, red tongue, yellow veins, number of strings, should be appropriate for liver and diarrhea.
  • the traditional Chinese medicine preparation on the basis of the clinical expert's experience in treating Chinese medicine for anxiety for many years, through the treatment of the traditional Chinese medicine preparation combined with ⁇ in the treatment of generalized anxiety disorder qi and blood deficiency syndrome Safety verification, the traditional Chinese medicine preparation of the invention has a good effect of promoting the treatment of generalized anxiety disorder syndrome of qi and blood deficiency, reducing the use of western medicine, reducing the side effects of western medicine, and having no toxic and side effects, and is suitable for The traditional Chinese medicine preparation of the invention is clinically applied.
  • the technical problem to be solved by the present invention is to provide a traditional Chinese medicine preparation for treating a generalized anxiety disorder with qi and blood deficiency syndrome type.
  • the traditional Chinese medicine preparation of the present invention is based on theoretical research, and has been used by clinical experts for many years to treat anxiety disorders.
  • the therapeutic effect of the traditional Chinese medicine preparation combined with ⁇ in the treatment of generalized anxiety disorder qi and blood deficiency syndrome type and safety verification the Chinese medicinal preparation of the invention has a good promotion of ⁇ therapy for generalized anxiety disorder qi and blood Insufficient syndrome type, reduce the use of western medicine, reduce the side effects of western medicine, and have no toxic and side effects, and is suitable for clinical application of the traditional Chinese medicine preparation of the invention.
  • the present invention provides a traditional Chinese medicine preparation for treating a generalized anxiety disorder with qi and blood deficiency syndrome, and the raw materials thereof include Suanzaoren, Angelica, Angelica, Rehmannia glutinosa, Chuan Bend, Ejiao, Ginseng, Astragalus, Codonopsis pilosula, and licorice , jujube, floating wheat, French pinellia, gallbladder, orange peel, Bupleurum, turmeric, day lily, ⁇ , Shouwu vine and Yuanzhi.
  • the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 25 parts by weight to 40 parts by weight of Suanzaoren, 30 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 35 parts by weight of Radix Rehmanniae, Rehmannia glutinosa 20 Parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophan, 35 parts by weight to 40 parts by weight of ginseng, 30 parts by weight to 45 parts by weight of scutellaria, 25 parts by weight of ginseng to 35 Parts by weight, licorice 15 parts by weight to 25 parts by weight, jujube 10 parts by weight to 25 parts by weight, floating wheat 10 parts by weight to 15 parts by weight, French Pinellia 15 parts by weight to 20 parts by weight, uranium star 10 parts by weight 15 parts by weight, Chenpi 15 parts by weight to 20 parts by weight, Bupleurum
  • the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight to 35 parts by weight of Suanzaoren, 35 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 30 parts by weight of Radix Rehmanniae, Rehmannia glutinosa 25 Parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophan, 35 parts by weight to 40 parts by weight of ginseng, 35 parts by weight to 40 parts by weight of scutellaria, 30 parts by weight of ginseng to 35 parts by weight 15 parts by weight to 20 parts by weight of licorice, 15 parts by weight to 20 parts by weight of jujube, 10 parts by weight to 15 parts by weight of floating wheat, 15 parts by weight to 20 parts by weight of Banxia, and 10 parts by weight of uranium.
  • the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight of Suanzaoren, 35 parts by weight of Angelica, 30 parts by weight of Radix, 25 parts by weight of Radix Rehmanniae, 25 parts by weight of Chuanxiong, and 30 parts by weight of Ejiao.
  • the present invention also provides a traditional Chinese medicine injection for treating generalized anxiety disorder syndrome of qi and blood deficiency, and the raw materials thereof include Suanzaoren, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ginseng, Astragalus, Codonopsis pilosula, Poria Licorice, jujube, floating wheat, French pinellia, gallbladder, orange peel, Bupleurum, turmeric, day lily, ⁇ , Shouwu vine and Yuanzhi.
  • the weight of each raw material in the traditional Chinese medicine injection is 25 parts by weight of the Suanzaoren to 40 parts by weight, 30 parts by weight of Angelica to 40 parts by weight, 25 parts by weight of the white peony to 35 parts by weight, Rehmannia glutinosa 20 parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophane, 35 parts by weight to 40 parts by weight of ginseng, 30 parts by weight to 45 parts by weight of astragalus, and 25 parts by weight of ginseng to 35 Parts by weight, licorice 15 parts by weight to 25 parts by weight, jujube 10 parts by weight to 25 parts by weight, floating wheat 10 parts by weight to 15 parts by weight, French Pinellia 15 parts by weight to 20 parts by weight, uranium star 10 parts by weight 15 parts by weight, dried tangerine peel 15 parts by weight to 20 parts by weight, Bupleurum 15 parts by weight to
  • the present invention also provides a method for preparing the above traditional Chinese medicine injection, which comprises:
  • each raw material drug is broken into coarse powder, mixed together, and ethanol having an alcohol concentration of 80% relative to the mass of the mixture is added, and the mixture is wetted for 12 hours, and then packed into a column for infiltration.
  • the percolate is ethanol with an alcohol concentration of 80%
  • the amount of ethanol used is 15 to 20 times the mass of the mixture
  • the percolation rate is 5 ml.min - kg -1
  • the percolate is collected, and concentrated under reduced pressure to 65 ° C.
  • the first step of obtaining the extract is added to the alcohol having an alcohol concentration of 80% in a volume ratio of 1:1, and the mixture is kept at a temperature of 2 to 5 ° C for 24 to 48 hours, and the precipitate is removed by filtration; Recover under reduced pressure, obtain dry paste, pulverize into powder, add water for injection to 80% of the required preparation volume, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 10 ⁇ 30 minutes, remove activated carbon by filtration, add water for injection to 100% of the required volume of the preparation; filtered through a 0.2 2 ⁇ filter, adjusting the temperature of the filtrate to 30 ° C to 50 ° C, using an ultrafiltration membrane with a molecular weight cut off of 8000 to 30000, at a pressure of 0.05 to 0.3 MPa. Filtration, ultrafiltrate is potted, sterilized, packaged.
  • the traditional Chinese medicine preparation of the invention is based on the summary of the experience of clinical experts for treating anxiety in many years, and the invention relates to the treatment of generalized anxiety disorder with qi and blood deficiency syndrome by combining the traditional Chinese medicine preparation with the new Chinese medicine preparation.
  • the efficacy observation and safety verification, the traditional Chinese medicine preparation for the generalized anxiety disorder qi and blood deficiency syndrome type has a good role in promoting the new treatment of ⁇ , reducing the use of western medicine, reducing the side effects of western medicine, and no toxic side effects It is suitable for clinical application of the traditional Chinese medicine preparation of the invention.
  • the present invention provides a Chinese medicine preparation for treating generalized anxiety disorder with qi and blood deficiency syndrome, and the raw materials thereof include Suanzaoren, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ginseng, Huang Wei, Codonopsis pilosula, licorice, jujube, floating wheat, French pinellia, biliary star, orange peel, Bupleurum, turmeric, day lily, ⁇ , Shouwu vine and Yuanzhi.
  • the prescription of the invention has clear thinking, proper use of medicine, and simple dosage, and can well treat the syndrome of qi and blood deficiency of generalized anxiety disorder.
  • the traditional Chinese medicine preparation is prepared only from the above-mentioned raw material medicine.
  • the weight fraction of each raw material in the traditional Chinese medicine preparation is 25 parts by weight to 40 parts by weight of Suanzaoren, 30 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 35 parts by weight of white peony, and 20 parts by weight of Rehmannia glutinosa.
  • the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight to 35 parts by weight of Suanzaoren, 35 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 30 parts by weight of radix rehmanniae, Rehmannia glutinosa 25 parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophane, 35 parts by weight to 40 parts by weight of ginseng, 35 parts by weight to 40 parts by weight of astragalus, and 30 parts by weight of ginseng to 35 15 parts by weight to 20 parts by weight of licorice, 15 parts by weight to 20 parts by weight of jujube, 10 parts by weight to 15 parts by weight of floating wheat, 15 parts by weight to 20 parts by weight of Banxia, and 10 parts by weight of uranium.
  • the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight of Suanzaoren, 35 parts by weight of Angelica sinensis, 30 parts by weight of Radix, 25 parts by weight of Rehmannia glutinosa, 25 parts by weight of Chuanxiong, and 30 parts by weight of Ejiao.
  • Suanzaoren sweet, sour, flat, with nourishing heart and liver, soothe the nerves, the effect of sweat, attending virtual annoyance; convulsions; physical weakness, sweating, night sweats and other cards.
  • Angelica L name angelicae sinensis radix, sweet, Xin, sexual temperature, into the liver, heart, spleen, have blood and blood circulation, regulate menstruation and pain, the role of laxative, mainly for dizziness, lack of blood, Burnout, palpitations, shortness of breath, and other signs of blood deficiency; blood and sea emptiness, irrespective of irregular menstruation , menstrual pain, birth or abdominal pain, and other blood stasis pain and yin deficiency blood less constipation and other symptoms of constipation.
  • White peony bitter, sour, slightly cold, liver, spleen, with nourishing and regulating menstruation, yin and yin, soft liver and pain, calming liver and yang, attending blood deficiency and chlorosis, irregular menstruation, Self-sweat, night sweats, hypochondriac pain, abdominal pain, limb pain, dizziness and dizziness.
  • Rehmannia glutinosa sweet, sexually lukewarm, into the liver, kidney, with blood and nourishing yin, Yijing fill the effect of the marrow, attending blood deficiency and chlorosis; dizziness, palpitations, insomnia, irregular menstruation, collapse; liver and kidney Yin deficiency, night sweats, pain in the feet and knees, weak waist and knees, tinnitus and deafness, head fainting; nocturnal impotence; infertility; irregular menstruation; blood leaking; early white; thirst; constipation; kidney deficiency and asthma .
  • Ejiao sweet, flat, into the lungs, liver, kidney, have blood and stop bleeding, nourishing yin and moisturizing effect, can be used for a variety of symptoms of fatigue, especially the complexion of blood deficiency, sallow, weak and weak, Head stun, palpitations and insomnia; malnutrition anemia, thrombocytopenic purpura; septic hemoptysis; vomiting blood and blood in the stool; yin deficiency and lung dry cough and pharyngeal dryness, sputum with blood; evil heat for a long time, yin deficiency blood consumption In the virtual wind, the veins are in a hurry, and the hands and feet are convulsive.
  • Ginseng sweet, slightly bitter, sexually lukewarm, into the heart, lungs, spleen, have a great vitality, qi and Yifei, Shengjinzhike, Anshen puzzle and other effects, not only for the rescue and relief
  • the agent is also the first medicine for treating internal injuries. All the evidences of deficiency of blood can be applied. Indications for fatigue, loss of food, fatigue, nausea, diarrhea, diarrhea, and cough Sweat violent, convulsions, forgetfulness, dizziness, headache, impotence, frequent urination, thirst, uterine bleeding, pediatric slowness and long absences.
  • Astragalus name astragali radix, sweet, warm, into the spleen, lung, have beneficial spleen, lift yang, solid table antiperspirant, sore muscles and other effects, mainly used for spleen and lung qi deficiency Caused by lack of energy, less food, shortness of breath, shortness of breath, sag of the sag of the gas, stagnation of the blood without blood, long-term diarrhea, rectal prolapse, self-perspiration, night sweats, lack of blood and other evidence.
  • Codonopsis pilosula sweet, flat, into the lungs, spleen, have qi and spleen, nourishing blood and fluid, mainly used for spleen and lung qi deficiency or qi and blood deficiency, fatigue, shortness of breath, cough, spontaneous sweating, etc.
  • Symptoms, the party's ginseng in the spleen and stomach, conditioning the coke, and have the role of nourishing blood, its sexuality, spleen and transport is not dry; taste yin but not wet, can change Improve the immune status of the body, improve disease resistance, promote digestion and absorption, and improve metabolism.
  • Zhigancao sweet, flat, into the twelve classics, to reconcile the drug, to relieve cough, and to strengthen the spleen and
  • relieve pain mainly used to replenish spleen and replenish qi, clearing away heat and detoxification, relieving cough, relieving pain, reconciling various medicines
  • jujube the name jujubaefmct, sweet, warm, spleen, stomach, with spleen and stomach, Yiqi Shengjin, adjust the camp Wei, antidote to the effect of drugs, attending stomach deficiency, less spleen Note, lack of blood and fluid, camp and peace, heart palpitations. The woman is waiting for the card.
  • Floating wheat Latin name Gramim ⁇ e, cool, sweet and salty, effective anti-sweat, nourish the heart and soothe the nerves. For physical and sweaty, viscera. It is not appropriate to use self-perspiration and night sweats caused by yin and yang deficiency.
  • French Pinellia Weixin, sexual temperature, spleen, stomach, lung, with the effect of dampness and phlegm, attending more cough
  • Gallic star bitter, slightly pungent, cool, return to the lungs, liver, spleen, with heat and phlegm, the effect of the wind and wind, used for hot cough, phlegm yellow thick, stroke entertained, Epilepsy and other evidence.
  • Chenpi Sexual temperature, Weixin, bitterness; return to the spleen, lung, spleen and warm, smelly, longer than qi, can enter the spleen and lungs, so it can not only disperse the lungs, but also the width In the case of lung gas stagnation, chest fullness and spleen and stomach stagnation, abdominal distension and other evidence.
  • Bupleurum pulled the name bupleuri mdix, the dry root of the umbelliferous plant Bupleurum or Bupleurum chinense, slightly cold
  • It has the functions of heat dissipation and sterilization, and it has the functions of heat dissipation and bactericidal treatment. It treats cold, fever, cold and heat, malaria, liver qi stagnation, chest rib pain, rectal prolapse, uterine shedding, irregular menstruation and so on.
  • turmeric Weixin, bitter, cold, liver, heart, lung, with the effect of gasification, clear heart and stagnation, spleen and yellowing, attending menstrual dysmenorrhea, chest and abdomen pain, tingling , fever, fainting, epilepsy, jaundice, urinary red and other evidence.
  • Sweet, flat, with the effect of calming the liver and soothe the nerves, attending convulsions and forgetfulness, strokes, speech, and athlete's foot.
  • Shouwu vine sweet, flat, heart, liver, with nourishing blood and soothe the nerves, the effect of phlegm and blood circulation, the main treatment Sleep more dreams, bloody body pain, rheumatism and pain; skin itching and other evidence.
  • Yuanzhi taste bitter, Xin, sexual lukewarm, heart, kidney, lung, with the effect of soothe the nerves, phlegm, swelling, for insomnia caused by heart and kidney, dreams, forgetfulness, romance , Cough is not good, sore swollen poison, breast swelling and so on.
  • the extract is mixed with a pharmaceutically acceptable carrier or diluent to prepare a preparation, and the dosage form of the preparation is preferably a tablet, a capsule, or a granule.
  • the agent, the pills, the oral solution or the injection, the injection is an injection, a suspension for injection, and a lyophilized powder.
  • the pharmaceutically acceptable carrier or diluent is one or more selected from the group consisting of a filler, a disintegrant, a binder, a lubricant, a flavoring agent, an osmotic pressure adjusting agent, or a surfactant.
  • the present invention also provides a method for preparing the above-mentioned medicament, which comprises:
  • each raw material drug is separately pulverized into coarse powder, mixed together, and ethanol having an alcohol concentration of 80% relative to the mass of the mixture is added, and the mixture is wet for 12 hours, and then packed into a column for infiltration.
  • the percolate is ethanol with an alcohol concentration of 80%
  • the amount of ethanol used is 15 to 20 times the mass of the mixture
  • the percolation rate is 5 ml.min - i.kg -i
  • the percolate is collected, and concentrated under reduced pressure to 65
  • the first step of obtaining the extract is added to the ethanol having an alcohol concentration of 80% in a volume ratio of 1:1, and is kept at a temperature of 2 to 5 ° C for 24 to 48 hours, and the precipitate is removed by filtration; Recover under reduced pressure, obtain dry paste, pulverize into powder, add water for injection to 80% of the required preparation volume, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 10 ⁇ 30 minutes, remove activated carbon by filtration, add water for injection to 100% of the required volume of the preparation; filtered through a 0.2 2 ⁇ filter, adjusting the temperature of the filtrate to 30 ° C to 50 ° C, using an ultrafiltration membrane with a molecular weight cut off of 8000 to 30000, at a pressure of 0.05 to 0.3 MPa. Filtration, ultrafiltrate is potted, sterilized, packaged.
  • the percolate is ethanol with an alcohol concentration of 80%.
  • the amount of ethanol used was 7.5 kg, the percolation rate was Sml.min kg -1 , the percolate was collected, and the extract was concentrated under reduced pressure to a extract having a relative density of 1.30 at 65 ° C.
  • the obtained extract was in a volume of 1:1.
  • ethanol with 80% alcohol concentration chilled at 2 ⁇ 5 °C for 48 hours, the precipitate was removed by filtration; the filtrate was recovered under reduced pressure to obtain a dry paste, which was pulverized into powder, and water for injection was added to the required volume of 80.
  • the percolate is ethanol with an alcohol concentration of 80%, the amount of ethanol used is 7.5 kg, and the percolation rate is 5 ml.min -i.kg -i, collected.
  • the percolate was concentrated under reduced pressure to an extract having a relative density of 1.30 at 65 ° C.
  • the obtained extract was added with ethanol having an alcohol concentration of 80% in a volume ratio of 1:1, and kept at a temperature of 2 to 5 ° C for 48 hours. ⁇ , remove the precipitate by filtration; recover the filtrate under reduced pressure, obtain a dry paste, pulverize into a powder, add water for injection to 80% of the volume of the desired preparation, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 30 minutes, remove by filtration Activated carbon, water for injection to the required preparation 100% by volume; filtered through a 0.22 ⁇ filter, adjusting the filtrate temperature to 30 ° C ⁇ 50 ° C, using ultrafiltration membrane with molecular weight cut off of 30000, ultrafiltration at a pressure of 0.05 MPa, ultrafiltrate irrigation Sealed, sterilized, packaged.
  • the percolate was ethanol with an alcohol concentration of 80%, and the amount of ethanol used. For 7.5 kg, the percolation rate was 5 ml.min -i.kg -i, the percolate was collected, and concentrated under reduced pressure to 65 ° C. The relative density of 1.30 was obtained. The obtained extract was added in a volume ratio of 1:1. Ethanol with an alcohol concentration of 80%, chilled at 2 to 5 ° C for 48 hours, and the precipitate was removed by filtration; the filtrate was recovered under reduced pressure to obtain a dry paste, which was pulverized into powder, and water for injection was added to 80% of the desired preparation volume.
  • mice Guinea pig, male and female, weighing 300-400 g (common grade), animals were kept in cages, each animal was numbered and weighed, and the experiment was carried out 3 days after quarantine observation. Subject animals were observed for appearance signs, behavioral activities, food intake and body weight. Breeding environment, room temperature 19 ⁇ 26°C, daily temperature difference ⁇ 4°C, relative humidity ⁇ ⁇ , day and night light and dark alternately 12h/12h.
  • Ovalbumin Huaying Biotechnology Co., Ltd.
  • the traditional Chinese medicine injection 1 prepared in the first embodiment of the present invention is processed into a high-purity traditional Chinese medicine injection solution of 20 ml (corresponding to the original drug amount of 435 g), which is equivalent to the high-purity injection of the traditional Chinese medicine preparation containing the crude drug 21.75 g/ml.
  • the drug was administered by injection at 0. 75 ml/kg body weight, stored at 4 ° C for use, and returned to wet temperature using hydrazine.
  • Active systemic allergy test 60 guinea pigs were randomly divided into 5 groups, 12 rats in each group: positive control group (ovalbumin 3 mg/only), negative control group (0.9% sodium chloride injection), the present invention
  • the high-dose group of Chinese medicine preparation injection was 0.75ml/kg
  • the middle dose group was 0.5ml/kg
  • the low-dose group was 0.25ml/kg.
  • Each group of guinea pigs was sensitized by intraperitoneal injection, once every other day for 5 times. On the 14th day after the last sensitization, the guinea pig hind limbs were administered with saphenous vein injection, and the challenge dose was twice the sensitizing dose.
  • the dose of animal is 100 times or more of the normal dose of the human body, and no toxic side effects occur.
  • the use of the traditional Chinese medicine preparation injection is high, medium and low dose, and the dosage is 0.467ml. 0.175ml, 0.0875ml, corresponding to the original Chinese medicine amount of 10.15725g, 3.80625g, 1.903125g, which is 140.1 times, 52.5 times, 26.25 times per kg of normal human body administration (0.0725g per kg of normal human body administration), Therefore, it can be proved that the injection of the traditional Chinese medicine preparation of the present invention is safe, and thus the safety of other dosage forms can be indirectly proved.
  • New Zealand white rabbits weighing 2.0 ⁇ 3.0kg (common grade), numbered and weighed each animal, and conducted experiments after 3 days of quarantine observation. Subject animals were observed for appearance signs, behavioral activities, food intake and body weight. Breeding environment, room temperature 19 ⁇ 26 °C, daily temperature difference ⁇ 4 °C, relative humidity 40 ⁇ 3 ⁇ 4 ⁇ 70 ⁇ 3 ⁇ 4, day and night light and dark alternately 12h/12h.
  • the injection solution 1 prepared in the traditional Chinese medicine example 1 of the present invention obtains 20 ml of high-purity traditional Chinese medicine injection (corresponding to the original drug amount of 435 g), which is equivalent to the high-purity injection of the traditional Chinese medicine preparation containing 21.75 g/ml of the crude drug. Store at 4 °C for backup and use ⁇ to return to wet temperature.
  • 21 normal healthy rabbits were randomly divided into 3 groups, namely, high, medium and low dose groups (the Chinese medicine preparation injection 0.5 ml/kg, 0.25 ml/kg, 0.125 ml/kg). Injecting the above drugs into the left ear of the rabbit vein, The right ear was instilled with an equal dose of 0.9% sodium chloride injection, once a day for 10 days, before the daily administration and 48 hours after the last administration, the animals and the injection site were visually observed to observe the presence or absence of redness at the injection site. Stimulation such as congestion. At the 48th hour after the last administration, half of the animals were sacrificed in each group.
  • high, medium and low dose groups the Chinese medicine preparation injection 0.5 ml/kg, 0.25 ml/kg, 0.125 ml/kg.
  • the ear vein was injected to the centripetal direction (avoiding the injection site) 2cm, and the three vessels were continuously taken along with the surrounding tissue. Each segment was fixed by 10% formaldehyde solution. Histopathological examination revealed venous vascular tissue with or without inflammatory response, and even significant stimuli such as degeneration and necrosis. The remaining animals were observed for 21 days before histopathological examination to understand the reversibility of the irritating response. During the experiment, no symptoms of irritation were observed in the left and right ear of the experimental animals, and the stimulation response score was 0.
  • Symptom criteria Mainly due to persistent primary anxiety symptoms, and meet the following two items: 1 Frequent or persistent consciously uncontrollable fear or fearlessness of clear objects and fixed content; 2 Autonomic function Disordered or uneasy;
  • Main card (1) Qing Xuan Yin (2) Good thinking and worry (3) Good fear and anxiety
  • Second card (1) Dizziness, pale complexion (2) Self-sweat weakness (3) Insomnia and dreams (4) Chest tightness
  • the age is between 18-65 years old (including 18 years old, 65 years old)
  • the treatment group using the Chinese medicine preparation prepared by the embodiment 1 of the present invention, the high-purity injection solution, 20 ml injection is added with 0.9% sodium chloride to prepare 100 mT injection, intravenous drip, 100 drops/min, once daily injection.
  • the course of treatment is 4 weeks.
  • Control group treated with ⁇ (flupirtine tamoxifen tablets), taking: 1 tablet daily, morning morning, 4 weeks of treatment ( ⁇ produced by H.Lundbeck, Denmark) , lO.smg / piece, 20 pieces / box).
  • Flutethiophene is a thioxanthine blocker with low-dose anti-anxiety and anti-depressant effects.
  • Merlitexine is a biphasic antidepressant, low-dose sputum, excitatory, two components The combination has antidepressant, anxiolytic and excitatory properties.
  • HAMA Hamilton Anxiety Scale
  • TCM symptom evaluation criteria (measured before treatment and at the 2nd and 4th weekend of treatment)
  • TCM symptom score score reduction rate 70%, but ⁇ 90 ⁇ 3 ⁇ 4;
  • the database was established with E XC el2013, including: name, gender, age, duration of disease, HAMA scale score and TCM symptom scale score (pre-treatment, treatment after 2 and 4 weeks).
  • the software performs statistical analysis and graph production count data by frequency and percentage; the measurement data is expressed by mean and standard deviation, the count data is X2 test, and the measurement data is considered statistically significant by t test P ⁇ 0.05.
  • the HAMA scale integral evaluation and the TCM syndrome score evaluation results were slightly different.
  • the treatment of the HAMA score was similar to the Western medicine group in the 2 weeks after treatment, and the Chinese medicine group was better than the western medicine group in the treatment of 4 weeks.
  • the results of the two scoring standards were the same, and the efficacy of the Chinese medicine group was better than that of the western medicine group. This may be because the TCM Symptom Scale mainly observes the subjective symptoms of the patients, and the assessment focuses on the HAMA scale, thus resulting in differences in assessment conclusions.
  • the traditional Chinese medicine injection has a remarkable curative effect on the generalized anxiety syndrome of the syndrome of deficiency of blood and blood, and the short-term curative effect is similar to that of the new force, and the long-term curative effect is superior to that of the new force, and no obvious adverse reaction. Therefore, it is considered that the therapeutic effect of the traditional Chinese medicine preparation of the invention has the characteristics of long-lasting effect and less adverse reactions, and the patient's acceptance of the traditional Chinese medicine is higher than that of the western medicine.
  • Injectable solution 1 prepared in Example 1 of the present invention diazepam (DXP), specification: tablet, 2.5 mg per tablet
  • Rat open field experiment box model XR-XZ301, size: 50cmx50cmx40cm;
  • Rat elevated plus maze (EPM), model XR-XG201, EPM palace size: arm width 10cm, arm length 50cm, arm height 30cm; [0190] Xmaze animal behavior analysis system, model XR-Xmaze, the above instruments are all purchased from Shanghai Xinsoft Information Technology Co., Ltd.;
  • the rats were subjected to the open field experiment after 1 week of adaptation, and 60 rats with similar scores in the open field experiment were selected and randomly divided into 6 groups, 10 in each group, namely blank group, model group, DXP. Group, HFM (high-dose group of Chinese medicine preparations of the present invention) group, MFM (dose group of Chinese medicine preparations of the present invention) group, LFM (low-dose group of Chinese medicine preparations of the present invention) group.
  • an anastomosis rat model was prepared by the foot-shock method.
  • This model is a classic method in the animal emotional pathogenic model, that is, the modeled rat is placed in an adjustable noise electric stimulation cage, and the rat foot and body are in the body.
  • the electric stimulation is accompanied by noise stimulation, and the noise is combined to establish the conditioned reflection.
  • the noise can achieve the same effect as the previous electric shock.
  • the modeling conditions are set: 2 in the day (5 min interval), 3 in the night (interval lOmin), medium intensity current 0.5 mA, voltage 2700-3300 v, pulse
  • the width is 0.3s, lasts for 12 days, and the electrical stimulation condition can be tolerated in rats.
  • the rats have irritating, nervous, squatting, jumping and other emotional hyperactivity reactions, which is similar to clinical anxiety.
  • the patient is nervous, irritating and other manifestations.
  • the preparation of an anxious animal model using this method is more consistent with the symptomatic manifestations of the disease.

Abstract

Provided is a traditional Chinese medicine preparation for treating qi and blood deficiency-type generalized anxiety disorder. The medicinal raw materials thereof comprise spina date seed, angelica sinensis, radix paeoniae alba, radix rehmanniae praeparata, ligusticum wallichii, donkey-hide gelatin, ginseng, astragalus membranaceus, codonopsis pilosula, honey-fried licorice root, fructus ziziphi jujubae, fructus tritici levis, rhizoma pinellinae praeparata, arisaema cum bile, pericarpium citri reticulatae, radix bupleuri, radix curcumae, foldleaf daylily root, poria with hostwood, caulis polygoni multiflori, and polygala tenuifolia. On the basis of theoretical research, by means of observations of curative effect and verification of the safety of the traditional Chinese medicine preparation combined with Deanxit in treating generalized anxiety disorder, the preparation has a good effect for promoting Deanxit in treatment of generalized anxiety disorder, reduces the usage amount of western medicines and reduces toxic and side effects of western medicines, and is suitable for clinical expansion and application.

Description

技术领域  Technical field
[0001] 本发明涉及中医药技术领域, 尤其涉及一种治疗广泛性焦虑症气血不足证型的 中药制剂。  [0001] The present invention relates to the technical field of traditional Chinese medicine, and in particular to a traditional Chinese medicine preparation for treating a syndrome of generalized anxiety disorder.
背景技术  Background technique
[0002] 广泛性焦虑症 (generalizedalixietydis-order, GAD) 是指一种以缺乏明确对象 和具体内容的提心吊胆以及紧张不安为主的焦虑症, 并有显著的自主神经症状 、 肌肉紧张、 运动性不安。 焦虑吋的身体变化有肌肉高度紧张、 呼吸加快、 血 压升高、 出汗、 头晕、 胸闷、 心悸、 震颤、 尿急、 尿频、 呕吐、 腹胀腹泻等; 心理变化有兴奋不己、 思想专注集中于某事、 烦躁不安及情绪、 思维方式改变 ; 行为变化有警觉水平过高, 处理事物不容易集中精力, 对日常生活中的事物 失去兴趣等, 患者因难以忍受又无法解脱而感到痛苦。 随着现代社会工作生活 的节奏加快, 人们心理压力的增加, GAD的发病率呈逐年上升趋势, 据 WHO报 告: 1998年精神神经疾患发病占全球因疾病操作而致残和丧失生产能力人口的 1 2% , 其中高收入国家占 23%, 我国大陆地区的调査数据显示, 焦虑障碍 (主要 为焦虑症) 年患病率上海和北京分别是 2.4%和 3.2%。 现代医学对焦虑症的病因 [0002] Generalized alexiety dis-order (GAD) refers to an anxiety disorder characterized by lack of clear objects and specific content, as well as significant autonomic symptoms, muscle tension, and exercise uneasiness. . Anxious physical changes include high muscle tension, rapid breathing, high blood pressure, sweating, dizziness, chest tightness, palpitations, tremors, urgency, frequent urination, vomiting, bloating, diarrhea, etc.; psychological changes are excitable, and thoughts are focused on Some things, irritability and emotions, changes in thinking style; behavioral changes are too high level of alertness, dealing with things is not easy to concentrate, loss of interest in things in daily life, etc., patients feel unbearable and unable to relieve and feel pain. With the accelerated pace of work and life in modern society and the increase in people's psychological stress, the incidence of GAD is increasing year by year. According to the WHO report: In 1998, the incidence of mental and neurological diseases accounted for the global disability and loss of productive capacity due to disease operations. 2%, of which high-income countries accounted for 23%. According to survey data from mainland China, the annual prevalence of anxiety disorders (mainly anxiety disorders) was 2.4% and 3.2% in Shanghai and Beijing, respectively. The cause of anxiety in modern medicine
、 发病机制及治疗都进行了深入的研究, 焦虑的常见诱因为心理冲突, 发病机 制可能为去甲肾上腺素 (NE) 能活动的增加, 5-羟色胺 (5-HT) 功能和多巴胺 功能失调, 现代医学对此症的治疗主要为药物干预和心理调节两方面, 药物治 疗包括三环类抗抑郁药 (TCAs) 、 可逆和不可逆性单胺氧化酶抑制剂 (MA015 ) 、 高效苯二氮卓类 (BZDs) 药物、 选择性五羟色胺再摄取阻断剂 (SSRIs) 等 , 虽可取得一定疗效, 但具有成瘾性、 耐药性较强, 副作用较多的缺点。 心理 治疗也己被证明有效, 且与药物治疗同吋应用可降低复发率, 焦虑症在祖国医 学中属情志病范畴, 虽无焦虑症的病名, 但与郁病、 卑喋、 奔豚、 百合病等均 有关, 现代中医认为焦虑症的发生多因情志不遂, 肝郁气滞, 或兼痰火扰心、 心火旺盛、 心神不宁、 气血不足、 肝郁血虚、 肾精不足、 肝胆不足, 故而治疗 应以疏肝理气为主, 兼顾心、 肝、 肾三脏。 近年来对于中医药治疗焦虑症的研 究逐渐增多, 其结果表明中医药治疗本病在取得良好疗效的同吋, 明显降低了 副作用及药物依赖性。 The pathogenesis and treatment have been thoroughly studied. The common cause of anxiety is psychological conflict. The pathogenesis may be an increase in norepinephrine (NE) activity, 5-hydroxytryptamine (5-HT) function and dopamine dysfunction. Modern medical treatment of this disease is mainly in the two aspects of drug intervention and psychological regulation. Drug treatment includes tricyclic antidepressants (TCAs), reversible and irreversible monoamine oxidase inhibitors (MA015), and high-efficiency benzodiazepines (BZDs). Drugs, selective serotonin reuptake blockers (SSRIs), etc., can achieve certain therapeutic effects, but have the disadvantages of high addiction, strong drug resistance, and many side effects. Psychotherapy has also been proven to be effective, and the use of drug therapy can reduce the recurrence rate. Anxiety is a category of emotional illness in the motherland medicine. Although there is no disease name, it is associated with depression, despicableness, and porpoise. Lily diseases are all related. Modern Chinese medicine believes that the occurrence of anxiety disorders is mostly due to emotional stagnation, liver qi stagnation, or stagnation of fire, heart fire, restlessness, lack of blood, liver qi stagnation, kidney essence Insufficient, hepatobiliary deficiency, and treatment Should be based on Shugan Liqi, taking care of the heart, liver, kidney three organs. In recent years, research on the treatment of anxiety disorders with Chinese medicine has gradually increased. The results show that Chinese medicine has a good effect on the treatment of this disease, which significantly reduces side effects and drug dependence.
[0003] 现代医家对焦虑的产生观点不一, 主要为如下几类:  [0003] Modern physicians have different opinions on anxiety, mainly in the following categories:
[0004] (1) 肝郁气滞 [0004] (1) Liver qi stagnation
[0005] 长期持久的情志不遂, 或郁怒伤肝, 使肝失疏泄, 气失条达, 故终日多思善疑 , 精神忧郁, 善太息, 心神不宁, 两胁胀痛, 痛无定处, 腹胀纳差, 或咽中不 适, 如物梗阻, 舌淡红, 苔薄白, 脉弦, 治宜: 疏肝解郁。 王再超等等认为焦 虑症的产生以肝气郁结, 痰火郁结, 心神失养为病机, 病变以气机郁滞为主, 肝主疏泄的功能不能正常发挥, 进而导致气血阴阳失调而致病, 气血互用、 肝 气郁结则血行不畅, 日久成瘀, 肝郁横逆犯脾, 脾失健运, 气血生化乏源, 则 气滞血瘀更甚, 且可致血不养心而神失所主, 病久更可入络, 从而使病情缠绵 难愈。  [0005] Long-lasting and unrelenting emotions, or anger and anger, so that the liver is lost and suffocated, and the gas is lost, so that all doubts, mental depression, goodness, restlessness, painfulness, pain Nowhere, abdominal distension, or pharyngeal discomfort, such as obstruction, pale tongue, thin white fur, pulse string, should be appropriate: Shugan Jieyu. Wang Zaichao and so on think that the occurrence of anxiety disorder is caused by liver qi stagnation, smoldering stagnation, heart dystrophy as a pathogenesis, lesions mainly due to qi stagnation, and the function of liver stagnation is not functioning properly, which leads to qi and yin dysfunction. Disease, qi and blood mutual use, liver qi stagnation, blood flow is not smooth, long-term sputum, liver stagnation against the spleen, spleen lost health, qi and blood biochemical sources, qi stagnation and blood stasis is more, and can cause blood without The heart is lost to the Lord, and the disease can be entangled for a long time, thus making the disease difficult to heal.
[0006] (2) 气郁化火  [0006] (2) Qi Yuhuahuo
[0007] 肝气不疏, 肝气郁结日久, 气郁化火, 可出现急躁易怒, 胸闷胁胀, 头痛目赤 [0007] Liver gas is not sparse, liver qi stagnation for a long time, qi stagnation, can appear irritable, chest tightness, bloating, headache
, 口苦, 嘈杂泛酸, 便结尿黄, 舌红苔黄脉弦数, 治宜疏肝泻火。 , mouth bitter, noisy pantothenic acid, will be urinary yellow, red tongue, yellow veins, number of strings, should be appropriate for liver and diarrhea.
[0008] (3) 痰火扰心 [0008] (3) bonfire
[0009] 此证因素体痰盛, 或暴怒伤肝, 气郁化火, 灼津成痰, 痰火上扰, 致心神不安 , 易惊易怒, 惶惶不安, 临床表现为惊恐不安、 伴性急多言、 甚则躁狂、 头昏 、 头痛、 口苦等, 舌苔为舌红苔黄厚腻、 脉弦滑数, 治宜清心豁痰。  [0009] The factors of this syndrome are prosperous, or anger and anger, liver qi stagnation, smoldering, smoldering, anger, irritability, irritability, irritability, clinical manifestations of panic and anxiety More words, even madness, dizziness, headache, bitterness, etc., the tongue is red and yellow, the tongue is red and greasy, the pulse string is slippery, and the blood pressure is clear.
[0010] (4) 心神不宁  [0010] (4) Uneasy
[0011] 平素胆怯之人, 由于突受惊恐, 致心惊神摇, 不能自主, 渐至稍惊或无惊则恐 惧紧张、 坐立不安, 表现为善恐易惊, 坐卧不安, 舌苔薄白, 脉虚数, 治则: 养心安神, 镇惊定志。  [0011] The timid person, because of the sudden panic, is shocked, unable to be autonomous, gradually becoming a little shocked or not surprised, but fearful and nervous, fidgeting, showing good fear and fear, sitting restless, thin white fur, Pulse imaginary number, rule of law: nourish the heart and calm the nerves, the town is shocked.
[0012] (5) 气血不足  [0012] (5) Insufficient blood
[0013] 祖国医学认为心主神, 若久病体虚或失血过多、 或思虑过度, 既耗伤心血又影 响脾胃生化之源, 使气血两亏、 心失所养, 故神不安而志不宁, 惶惶俱俱, 紧 张不安, 表现为善恐不安, 惶惶不宁, 伴气短, 自汗无力、 面色苍白无华、 脉 弱, 治则: 补益气血、 安神。 [0013] The motherland medicine believes that the heart of the gods, if the illness is too weak or excessive blood loss, or excessive thinking, both consumes blood and affects the source of spleen and stomach biochemistry, so that the blood and blood loss, the heart is lost, so the god is uneasy and restless, Everything is nervous, nervous, manifested as fear, restlessness, shortness of breath, self-sufficiency, paleness, and pulse Weak, rule: replenish qi and blood, soothe the nerves.
[0014] (6) 肝郁血虚  [0014] (6) Liver stagnation and blood deficiency
[0015] 情志不畅, 肝郁不舒, 化火灼津, 肝血受损, 则心血亦亏, 致肝不藏魂, 心不 主神, 神魂散乱, 易惊不安, 表现为善恐、 紧张、 伴胸胁胀满、 虚烦易怒、 苔 薄、 舌色暗或淡、 脉细弱, 治则: 养血舒肝、 理气、 宁神。  [0015] Unsatisfactory emotions, liver stagnation, smoldering, liver and blood damage, the heart and blood are also lost, causing the liver not to hide the soul, the heart is not the god, the spirit is scattered, easy to be disturbed, showing good fear, Nervous, with chest fullness, irritability, irritability, thin fur, dark or light tongue, weak pulse, rule: nourishing blood, soothing, qi, Ningshen.
[0016] 本发明中药制剂在理论研究的基础上, 在临床专家多年中药治疗焦虑症经验的 总结上, 通过对本发明中药制剂联合黛力新治疗广泛性焦虑症气血不足证型的 疗效观察及安全性验证, 本发明中药制剂针对性的具有很好的促进黛力新治疗 广泛性焦虑症气血不足证型的作用, 减少西药的使用量, 降低西药毒副作用, 并且无毒副作用, 适用于临床推广应用本发明中药制剂。  [0016] On the basis of theoretical research, the traditional Chinese medicine preparation on the basis of the clinical expert's experience in treating Chinese medicine for anxiety for many years, through the treatment of the traditional Chinese medicine preparation combined with 黛力新 in the treatment of generalized anxiety disorder qi and blood deficiency syndrome Safety verification, the traditional Chinese medicine preparation of the invention has a good effect of promoting the treatment of generalized anxiety disorder syndrome of qi and blood deficiency, reducing the use of western medicine, reducing the side effects of western medicine, and having no toxic and side effects, and is suitable for The traditional Chinese medicine preparation of the invention is clinically applied.
技术问题  technical problem
[0017] 发明内容本发明所要解决的技术问题是提供一种治疗广泛性焦虑症气血不足证 型的中药制剂, 本发明中药制剂在理论研究的基础上, 在临床专家多年中药治 疗焦虑症经验的总结上, 通过对本发明中药制剂联合黛力新治疗广泛性焦虑症 气血不足证型的疗效观察及安全性验证, 本发明中药制剂具有很好的促进黛力 新治疗广泛性焦虑症气血不足证型的作用, 减少西药的使用量, 降低西药毒副 作用, 并且无毒副作用, 适用于临床推广应用本发明中药制剂。  SUMMARY OF THE INVENTION The technical problem to be solved by the present invention is to provide a traditional Chinese medicine preparation for treating a generalized anxiety disorder with qi and blood deficiency syndrome type. The traditional Chinese medicine preparation of the present invention is based on theoretical research, and has been used by clinical experts for many years to treat anxiety disorders. In summary, the therapeutic effect of the traditional Chinese medicine preparation combined with 黛力新 in the treatment of generalized anxiety disorder qi and blood deficiency syndrome type and safety verification, the Chinese medicinal preparation of the invention has a good promotion of 黛力新therapy for generalized anxiety disorder qi and blood Insufficient syndrome type, reduce the use of western medicine, reduce the side effects of western medicine, and have no toxic and side effects, and is suitable for clinical application of the traditional Chinese medicine preparation of the invention.
[0018] 本发明提供一种治疗广泛性焦虑症气血不足证型的中药制剂, 其原料药包括酸 枣仁、 当归、 白芍、 熟地黄、 川弯、 阿胶、 人参、 黄芪、 党参、 炎甘草、 大枣 、 浮小麦、 法半夏、 胆南星、 陈皮、 柴胡、 郁金、 黄花菜、 茯神木、 首乌藤和 远志。  [0018] The present invention provides a traditional Chinese medicine preparation for treating a generalized anxiety disorder with qi and blood deficiency syndrome, and the raw materials thereof include Suanzaoren, Angelica, Angelica, Rehmannia glutinosa, Chuan Bend, Ejiao, Ginseng, Astragalus, Codonopsis pilosula, and licorice , jujube, floating wheat, French pinellia, gallbladder, orange peel, Bupleurum, turmeric, day lily, 茯神木, Shouwu vine and Yuanzhi.
[0019] 其中, 所述中药制剂中各原料药的重量份分别为酸枣仁 25重量份〜 40重量份、 当归 30重量份〜 40重量份、 白芍 25重量份〜 35重量份、 熟地黄 20重量份〜 30重 量份、 川芎 20重量份〜 25重量份、 阿胶 25重量份〜 30重量份、 人参 35重量份〜 4 0重量份、 黄芪 30重量份〜 45重量份、 党参 25重量份〜 35重量份、 炙甘草 15重量 份〜 25重量份、 大枣 10重量份〜 25重量份、 浮小麦 10重量份〜 15重量份、 法半 夏 15重量份〜 20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20重量 份、 柴胡 15重量份〜 25重量份、 郁金 20重量份〜 30重量份、 黄花菜 15重量份〜 2 0重量份、 茯神木 20重量份〜 25重量份、 首乌藤 20重量份〜 30重量份和远志 10重 量份〜 15重量份。 [0019] wherein, the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 25 parts by weight to 40 parts by weight of Suanzaoren, 30 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 35 parts by weight of Radix Rehmanniae, Rehmannia glutinosa 20 Parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophan, 35 parts by weight to 40 parts by weight of ginseng, 30 parts by weight to 45 parts by weight of scutellaria, 25 parts by weight of ginseng to 35 Parts by weight, licorice 15 parts by weight to 25 parts by weight, jujube 10 parts by weight to 25 parts by weight, floating wheat 10 parts by weight to 15 parts by weight, French Pinellia 15 parts by weight to 20 parts by weight, uranium star 10 parts by weight 15 parts by weight, Chenpi 15 parts by weight to 20 parts by weight, Bupleurum 15 parts by weight to 25 parts by weight, turmeric 20 parts by weight to 30 parts by weight, Day lily 15 parts by weight to 2 0 parts by weight, 20 parts by weight of 茯神木~ 25 parts by weight, 20 parts by weight to 30 parts by weight of Shouwu vine and 10 parts by weight to 15 parts by weight of Yuanzhi.
[0020] 其中, 所述中药制剂中各原料药的重量份分别为酸枣仁 30重量份〜 35重量份、 当归 35重量份〜 40重量份、 白芍 25重量份〜 30重量份、 熟地黄 25重量份〜 30重 量份、 川芎 20重量份〜 25重量份、 阿胶 25重量份〜 30重量份、 人参 35重量份〜 4 0重量份、 黄芪 35重量份〜 40重量份、 党参 30重量份〜 35重量份、 炙甘草 15重量 份〜 20重量份、 大枣 15重量份〜 20重量份、 浮小麦 10重量份〜 15重量份、 法半 夏 15重量份〜 20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20重量 份、 柴胡 20重量份〜 25重量份、 郁金 20重量份〜 25重量份、 黄花菜 15重量份〜 2 0重量份、 茯神木 20重量份〜 25重量份、 首乌藤 25重量份〜 30重量份和远志 10重 量份〜 15重量份。  [0020] wherein, the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight to 35 parts by weight of Suanzaoren, 35 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 30 parts by weight of Radix Rehmanniae, Rehmannia glutinosa 25 Parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophan, 35 parts by weight to 40 parts by weight of ginseng, 35 parts by weight to 40 parts by weight of scutellaria, 30 parts by weight of ginseng to 35 parts by weight 15 parts by weight to 20 parts by weight of licorice, 15 parts by weight to 20 parts by weight of jujube, 10 parts by weight to 15 parts by weight of floating wheat, 15 parts by weight to 20 parts by weight of Banxia, and 10 parts by weight of uranium. 15 parts by weight, Chenpi 15 parts by weight to 20 parts by weight, Bupleurum 20 parts by weight to 25 parts by weight, turmeric 20 parts by weight to 25 parts by weight, Day lily 15 parts by weight to 20 parts by weight, and 20 parts by weight of 茯神木~ 25 parts by weight, Shouwu vine 25 parts by weight to 30 parts by weight, and Yuanzhi 10 parts by weight to 15 parts by weight.
[0021] 其中, 所述中药制剂中各原料药的重量份分别为酸枣仁 30重量份、 当归 35重量 份、 白芍 30重量份、 熟地黄 25重量份、 川芎 25重量份、 阿胶 30重量份、 人参 40 重量份、 黄芪 40重量份、 党参 30重量份、 炙甘草 20重量份、 大枣 20重量份、 浮 小麦 10重量份、 法半夏 15重量份、 胆南星 10重量份、 陈皮 20重量份、 柴胡 20重 量份、 郁金 25重量份、 黄花菜 15重量份、 茯神木 20重量份、 首乌藤 25重量份和 远志 10重量份。  [0021] wherein, the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight of Suanzaoren, 35 parts by weight of Angelica, 30 parts by weight of Radix, 25 parts by weight of Radix Rehmanniae, 25 parts by weight of Chuanxiong, and 30 parts by weight of Ejiao. 40 parts by weight of ginseng, 40 parts by weight of astragalus, 30 parts by weight of Codonopsis pilosula, 20 parts by weight of licorice, 20 parts by weight of jujube, 10 parts by weight of floating wheat, 15 parts by weight of Pinellia ternata, 10 parts by weight of cucumin, and 20 weight of dried tangerine peel A portion, 20 parts by weight of Bupleurum, 25 parts by weight of turmeric, 15 parts by weight of day lily, 20 parts by weight of sassafras, 25 parts by weight of Shouwu vine and 10 parts by weight of Yuanzhi.
[0022] 本发明还提供一种治疗广泛性焦虑症气血不足证型的中药注射液, 其原料药包 括酸枣仁、 当归、 白芍、 熟地黄、 川芎、 阿胶、 人参、 黄芪、 党参、 炙甘草、 大枣、 浮小麦、 法半夏、 胆南星、 陈皮、 柴胡、 郁金、 黄花菜、 茯神木、 首乌 藤和远志。  [0022] The present invention also provides a traditional Chinese medicine injection for treating generalized anxiety disorder syndrome of qi and blood deficiency, and the raw materials thereof include Suanzaoren, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ginseng, Astragalus, Codonopsis pilosula, Poria Licorice, jujube, floating wheat, French pinellia, gallbladder, orange peel, Bupleurum, turmeric, day lily, 茯神木, Shouwu vine and Yuanzhi.
[0023] 其中, 所述中药注射液中各原料药的重量份分别为酸枣仁 25重量份〜 40重量份 、 当归 30重量份〜 40重量份、 白芍 25重量份〜 35重量份、 熟地黄 20重量份〜 30 重量份、 川芎 20重量份〜 25重量份、 阿胶 25重量份〜 30重量份、 人参 35重量份 〜40重量份、 黄芪 30重量份〜 45重量份、 党参 25重量份〜 35重量份、 炙甘草 15 重量份〜 25重量份、 大枣 10重量份〜 25重量份、 浮小麦 10重量份〜 15重量份、 法半夏 15重量份〜 20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20 重量份、 柴胡 15重量份〜 25重量份、 郁金 20重量份〜 30重量份、 黄花菜 15重量 份〜 20重量份、 茯神木 20重量份〜 25重量份、 首乌藤 20重量份〜 30重量份和远 志 10重量份〜 15重量份。 [0023] wherein, the weight of each raw material in the traditional Chinese medicine injection is 25 parts by weight of the Suanzaoren to 40 parts by weight, 30 parts by weight of Angelica to 40 parts by weight, 25 parts by weight of the white peony to 35 parts by weight, Rehmannia glutinosa 20 parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophane, 35 parts by weight to 40 parts by weight of ginseng, 30 parts by weight to 45 parts by weight of astragalus, and 25 parts by weight of ginseng to 35 Parts by weight, licorice 15 parts by weight to 25 parts by weight, jujube 10 parts by weight to 25 parts by weight, floating wheat 10 parts by weight to 15 parts by weight, French Pinellia 15 parts by weight to 20 parts by weight, uranium star 10 parts by weight 15 parts by weight, dried tangerine peel 15 parts by weight to 20 parts by weight, Bupleurum 15 parts by weight to 25 parts by weight, turmeric 20 parts by weight to 30 parts by weight, day lily 15 weight Parts to 20 parts by weight, 20 parts by weight of 茯神木~ 25 parts by weight, 20 parts by weight to 30 parts by weight of Shouwu vine and 10 parts by weight to 15 parts by weight of Yuanzhi.
[0024] 本发明还提供了上述中药注射液的制备方法, 其包括: [0024] The present invention also provides a method for preparing the above traditional Chinese medicine injection, which comprises:
[0025] 第一步, 将各原料药分别碎成粗粉, 混合在一起, 加入相对于混合物质量 1〜2 倍的醇浓度为 80%的乙醇, 润湿 12小吋, 随后装柱进行渗漉, 渗漉液为醇浓度为 80%的乙醇, 使用的乙醇量为混合物质量的 15〜20倍, 渗漉速度 5ml.min - kg -1 , 收集渗漉液, 减压浓缩至 65°C吋相对密度为 1.25〜1.30的浸膏; [0025] In the first step, each raw material drug is broken into coarse powder, mixed together, and ethanol having an alcohol concentration of 80% relative to the mass of the mixture is added, and the mixture is wetted for 12 hours, and then packed into a column for infiltration.漉, the percolate is ethanol with an alcohol concentration of 80%, the amount of ethanol used is 15 to 20 times the mass of the mixture, the percolation rate is 5 ml.min - kg -1 , the percolate is collected, and concentrated under reduced pressure to 65 ° C. An extract having a relative density of 1.25 to 1.30;
[0026] 第二步, 将第一步获得浸膏按照 1:1的体积比加入醇浓度为 80%的乙醇, 2〜5°C 冷藏静置 24〜48小吋, 过滤除掉沉淀; 滤液减压回收, 获得干膏, 粉碎成粉末 , 加注射用水至所需制剂体积的 80%, 加入注射级活性炭, 加热至微沸并保持 10 〜30分钟搅拌, 过滤除掉活性炭, 加注射用水至所需制剂体积的 100%; 次经 0.2 2μηι的滤膜过滤, 调节滤液温度至 30°C〜50°C, 用截留分子量 8000〜30000的超 滤膜, 在压力为 0.05〜0.3MPa下进行超滤, 超滤液经灌封、 灭菌、 包装。  [0026] In the second step, the first step of obtaining the extract is added to the alcohol having an alcohol concentration of 80% in a volume ratio of 1:1, and the mixture is kept at a temperature of 2 to 5 ° C for 24 to 48 hours, and the precipitate is removed by filtration; Recover under reduced pressure, obtain dry paste, pulverize into powder, add water for injection to 80% of the required preparation volume, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 10~30 minutes, remove activated carbon by filtration, add water for injection to 100% of the required volume of the preparation; filtered through a 0.2 2 μηι filter, adjusting the temperature of the filtrate to 30 ° C to 50 ° C, using an ultrafiltration membrane with a molecular weight cut off of 8000 to 30000, at a pressure of 0.05 to 0.3 MPa. Filtration, ultrafiltrate is potted, sterilized, packaged.
问题的解决方案  Problem solution
发明的有益效果  Advantageous effects of the invention
有益效果  Beneficial effect
[0027] 有益的技术效果 [0027] Advantageous technical effects
[0028] 本发明中药制剂在理论研究的基础上, 在临床专家多年中药治疗焦虑症经验的 总结上, 通过对本发明中药制剂联合黛力新有针对性的治疗广泛性焦虑症气血 不足证型的疗效观察及安全性验证, 本发明中药制剂针对广泛性焦虑症气血不 足证型, 具有很好的促进黛力新治疗的作用, 减少西药的使用量, 降低西药毒 副作用, 并且无毒副作用, 适用于临床推广应用本发明中药制剂。  [0028] On the basis of theoretical research, the traditional Chinese medicine preparation of the invention is based on the summary of the experience of clinical experts for treating anxiety in many years, and the invention relates to the treatment of generalized anxiety disorder with qi and blood deficiency syndrome by combining the traditional Chinese medicine preparation with the new Chinese medicine preparation. The efficacy observation and safety verification, the traditional Chinese medicine preparation for the generalized anxiety disorder qi and blood deficiency syndrome type, has a good role in promoting the new treatment of 黛力, reducing the use of western medicine, reducing the side effects of western medicine, and no toxic side effects It is suitable for clinical application of the traditional Chinese medicine preparation of the invention.
本发明的实施方式 Embodiments of the invention
[0029] 具体实施方式 DETAILED DESCRIPTION
[0030] 为解决上述技术问题, 本发明提供一种治疗广泛性焦虑症气血不足证的中药制 齐 ij, 其原料药包括酸枣仁、 当归、 白芍、 熟地黄、 川芎、 阿胶、 人参、 黄芪、 党参、 炙甘草、 大枣、 浮小麦、 法半夏、 胆南星、 陈皮、 柴胡、 郁金、 黄花菜 、 茯神木、 首乌藤和远志。 [0030] In order to solve the above technical problem, the present invention provides a Chinese medicine preparation for treating generalized anxiety disorder with qi and blood deficiency syndrome, and the raw materials thereof include Suanzaoren, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ginseng, Huang Wei, Codonopsis pilosula, licorice, jujube, floating wheat, French pinellia, biliary star, orange peel, Bupleurum, turmeric, day lily, 茯神木, Shouwu vine and Yuanzhi.
[0031] 该中药制剂的治疗原理如下:  [0031] The treatment principle of the traditional Chinese medicine preparation is as follows:
[0032] 一、 益气养血 [0032] First, benefit Qi and nourish blood
[0033] 祖国医学认为心主神, 若久病体虚或失血过多、 或思虑过度, 既耗伤心血又影 响脾胃生化之源, 使气血两亏、 心失所养, 故神不安而志不宁, 惶惶俱俱, 紧 张不安, 表现为善恐不安, 惶惶不宁, 伴气短, 自汗无力、 面色苍白无华、 脉 弱, 治则补益气血、 安神, 故本发明制剂, 运用酸枣仁补养心血, 当归、 白芍 、 熟地黄、 川芎、 阿胶、 滋阴养血, 阿胶为血肉友情之品, 应用阿胶补血力度 更强, 善治阴者当阳中求阴, 善补阳者当阴中求阳, 故方中加入人参、 黄芪、 党参、 炙甘草补脾益气, 其中人参大补人之元气, 黄芪、 当归为当归补血汤, 气血两补, 其效专力强, 党参、 炙甘草补脾益气, 顾护人之后天之本, 诸药合 用, 气血双补, 心血得充, 心气得健, 心神得安, 焦虑得平。  [0033] The motherland medicine believes that the heart of the gods, if the illness is too weak or excessive blood loss, or excessive thinking, both consumes blood and affects the source of spleen and stomach biochemistry, so that the blood and blood loss, the heart is lost, so the god is uneasy and restless, Everything is nervous, nervous and uneasy, manifested as good fear and restlessness, uneasy, shortness of breath, weak self-sweat, pale complexion, weak pulse, cure for qi and blood, soothe the nerves, so the preparation of the invention, using the jujube kernel to nourish the blood, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ziyin Yangxue, Ejiao is a flesh-and-blood friendship product, applying Ejiao blood to strengthen the blood, good governance Yin Dangyang in the yin, good-filling Yang as a yin in the yang, In the same way, ginseng, astragalus, codonopsis pilosula, licorice root spleen and qi spleen and qi are added, among which ginseng is a great remedy for glutathion, jaundice and angelica are angelica blood soup, qi and blood are two, and their effects are strong. Dangshen and licorice spleen Benefiting Qi, taking care of the people after the day, the various medicines are combined, the blood and blood are double-filled, the blood is filled, the heart is healthy, the mind is safe, and the anxiety is even.
[0034] 二、 涤痰幵窍  [0034] Second, polyester
[0035] 气血两虚为本病的根本病机, 然而气血不足的同吋, 往往伴有机体气血运化不 畅, 生痰生湿, 痰邪蒙蔽心窍, 多为神志昏蒙, 故本方加入涤痰幵窍、 疏肝理 气的药物, 使用法半夏、 胆南星、 陈皮燥湿化痰, 柴胡、 郁金配合陈皮舒肝理 气, 调畅全身气机, 诸药合用, 共奏涤痰幵窍之功。  [0035] Both qi and blood deficiency are the fundamental pathogenesis of this disease. However, the lack of qi and blood is often accompanied by poor blood transport of the organism, phlegm and dampness, sputum and sorrow, and most of them are fascinating, so The party added drugs for dissolving phlegm, soothing liver and regulating qi, using the method of Pinellia, biliary star, Chenpi dry phlegm, Bupleurum, turmeric with Chenpi Shugan qi, smoothing the whole body qi, combined with various drugs, Play the role of polyester.
[0036] 三、 宁心安神  [0036] Third, Ning Xin An Shen
[0037] 治疗本病补气养血的同吋, 应加入宁心安神的药物, 如大枣、 浮小麦、 黄花菜 、 茯神木、 首乌藤、 远志, 浮小麦可以敛心气, 心阴, 可以止汗, 黄花菜、 茯 神木、 首乌藤可以宁心安神, 调畅情志, 远志可以安神定志, 诸药合用, 可以 起到很好的宁心安神的功效。  [0037] The treatment of this disease qi and nourishing the same, should be added to the Ningxin Anshen drugs, such as jujube, floating wheat, day lily, 茯神木, Shouwu vine, Yuanzhi, floating wheat can gather heart, heart yin, It can stop sweating, day lily, 茯神木, Shouwu vine can calm the nerves, adjust the emotions, Yuanzhi can calm down the mind, all kinds of medicines can be used, can play a very good effect.
[0038] 本发明制剂组方思路清晰, 用药得当, 药量精简, 可以很好的治疗广泛性焦虑 症气血不足证。  [0038] The prescription of the invention has clear thinking, proper use of medicine, and simple dosage, and can well treat the syndrome of qi and blood deficiency of generalized anxiety disorder.
[0039] 进一步优选, 所述中药制剂仅由上述原料药制备而成。  [0039] Further preferably, the traditional Chinese medicine preparation is prepared only from the above-mentioned raw material medicine.
[0040] 所述中药制剂中各原料药的重量份分别为酸枣仁 25重量份〜 40重量份、 当归 30 重量份〜 40重量份、 白芍 25重量份〜 35重量份、 熟地黄 20重量份〜 30重量份、 川芎 20重量份〜 25重量份、 阿胶 25重量份〜 30重量份、 人参 35重量份〜 40重量 份、 黄芪 30重量份〜 45重量份、 党参 25重量份〜 35重量份、 炙甘草 15重量份〜 2 5重量份、 大枣 10重量份〜 25重量份、 浮小麦 10重量份〜 15重量份、 法半夏 15重 量份〜 20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20重量份、 柴 胡 15重量份〜 25重量份、 郁金 20重量份〜 30重量份、 黄花菜 15重量份〜 20重量 份、 茯神木 20重量份〜 25重量份、 首乌藤 20重量份〜 30重量份和远志 10重量份 〜 15重量份。 [0040] The weight fraction of each raw material in the traditional Chinese medicine preparation is 25 parts by weight to 40 parts by weight of Suanzaoren, 30 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 35 parts by weight of white peony, and 20 parts by weight of Rehmannia glutinosa. ~ 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophane, 35 parts by weight to 40 parts by weight of ginseng, 30 parts by weight to 45 parts by weight of astragalus, 25 parts by weight to 35 parts by weight of Codonopsis pilosula, and 15 parts by weight of licorice ~ 25 parts by weight, jujube 10 parts by weight to 25 parts by weight, floating wheat 10 parts by weight to 15 parts by weight, 15 parts by weight of the French midsummer to 20 parts by weight, uranium star 10 parts by weight to 15 parts by weight, dried tangerine peel 15 weight Parts to 20 parts by weight, Bupleurum 15 parts by weight to 25 parts by weight, turmeric 20 parts by weight to 30 parts by weight, day lily 15 parts by weight to 20 parts by weight, 茯神木 20 parts by weight to 25 parts by weight, Shouwu vine 20 Parts by weight to 30 parts by weight and 10 parts by weight of Yuanzhi to 15 parts by weight.
[0041] 进一步优选, 所述中药制剂中各原料药的重量份分别为酸枣仁 30重量份〜 35重 量份、 当归 35重量份〜 40重量份、 白芍 25重量份〜 30重量份、 熟地黄 25重量份 〜30重量份、 川芎 20重量份〜 25重量份、 阿胶 25重量份〜 30重量份、 人参 35重 量份〜 40重量份、 黄芪 35重量份〜 40重量份、 党参 30重量份〜 35重量份、 炙甘 草 15重量份〜 20重量份、 大枣 15重量份〜 20重量份、 浮小麦 10重量份〜 15重量 份、 法半夏 15重量份〜 20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份 〜20重量份、 柴胡 20重量份〜 25重量份、 郁金 20重量份〜 25重量份、 黄花菜 15 重量份〜 20重量份、 茯神木 20重量份〜 25重量份、 首乌藤 25重量份〜 30重量份 和远志 10重量份〜 15重量份。  [0041] Further preferably, the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight to 35 parts by weight of Suanzaoren, 35 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 30 parts by weight of radix rehmanniae, Rehmannia glutinosa 25 parts by weight to 30 parts by weight, 20 parts by weight to 25 parts by weight of chuanxiong, 25 parts by weight to 30 parts by weight of icophane, 35 parts by weight to 40 parts by weight of ginseng, 35 parts by weight to 40 parts by weight of astragalus, and 30 parts by weight of ginseng to 35 15 parts by weight to 20 parts by weight of licorice, 15 parts by weight to 20 parts by weight of jujube, 10 parts by weight to 15 parts by weight of floating wheat, 15 parts by weight to 20 parts by weight of Banxia, and 10 parts by weight of uranium. 15 parts by weight, Chenpi 15 parts by weight to 20 parts by weight, Bupleurum 20 parts by weight to 25 parts by weight, turmeric 20 parts by weight to 25 parts by weight, Day lily 15 parts by weight to 20 parts by weight, 茯神木 20 parts by weight to 25 Parts by weight, Shouwu vine 25 parts by weight to 30 parts by weight and Yuanzhi 10 parts by weight to 15 parts by weight.
[0042] 最优选, 所述中药制剂中各原料药的重量份分别为酸枣仁 30重量份、 当归 35重 量份、 白芍 30重量份、 熟地黄 25重量份、 川芎 25重量份、 阿胶 30重量份、 人参 4 0重量份、 黄芪 40重量份、 党参 30重量份、 炙甘草 20重量份、 大枣 20重量份、 浮 小麦 10重量份、 法半夏 15重量份、 胆南星 10重量份、 陈皮 20重量份、 柴胡 20重 量份、 郁金 25重量份、 黄花菜 15重量份、 茯神木 20重量份、 首乌藤 25重量份和 远志 10重量份。  [0042] Most preferably, the weight fraction of each raw material drug in the traditional Chinese medicine preparation is 30 parts by weight of Suanzaoren, 35 parts by weight of Angelica sinensis, 30 parts by weight of Radix, 25 parts by weight of Rehmannia glutinosa, 25 parts by weight of Chuanxiong, and 30 parts by weight of Ejiao. , 40 parts by weight of ginseng, 40 parts by weight of astragalus, 30 parts by weight of Codonopsis pilosula, 20 parts by weight of licorice, 20 parts by weight of jujube, 10 parts by weight of floating wheat, 15 parts by weight of Pinellia ternata, 10 parts by weight of bilirubin, and dried tangerine peel 20 parts by weight, 20 parts by weight of Bupleurum, 25 parts by weight of turmeric, 15 parts by weight of day lily, 20 parts by weight of eucalyptus, 25 parts by weight of Shouwu vine and 10 parts by weight of Yuanzhi.
[0043] 各原料药药理如下:  [0043] The pharmacology of each raw material is as follows:
[0044] 酸枣仁: 味甘、 酸, 性平, 具有滋养心肝, 安神, 敛汗的功效, 主治虚烦不眠 ; 惊悸怔忡; 体虚自汗、 盗汗等证。  [0044] Suanzaoren: sweet, sour, flat, with nourishing heart and liver, soothe the nerves, the effect of sweat, attending virtual annoyance; convulsions; physical weakness, sweating, night sweats and other cards.
[0045] 当归: L 名 angelicae sinensis radix, 味甘、 辛, 性温, 入肝、 心、 脾经, 有 补血活血, 调经止痛, 润肠通便的作用, 主要用于心血不足之头晕目眩, 倦怠 乏力, 心悸气短, 及其他血虚证; 血海空虚, 冲任虚寒或淤血阻滞之月经不调 , 经痛, 产或腹痛, 及其他血瘀作痛及阴虚血少肠燥之便秘等症状。 [0045] Angelica: L name angelicae sinensis radix, sweet, Xin, sexual temperature, into the liver, heart, spleen, have blood and blood circulation, regulate menstruation and pain, the role of laxative, mainly for dizziness, lack of blood, Burnout, palpitations, shortness of breath, and other signs of blood deficiency; blood and sea emptiness, irrespective of irregular menstruation , menstrual pain, birth or abdominal pain, and other blood stasis pain and yin deficiency blood less constipation and other symptoms of constipation.
[0046] 白芍: 味苦、 酸, 性微寒, 归肝、 脾经, 具有养血调经, 敛阴止汗, 柔肝止痛 , 平抑肝阳的功效, 主治血虚萎黄, 月经不调, 自汗, 盗汗, 胁痛, 腹痛, 四 肢挛痛, 头晕眩晕等证。  [0046] White peony: bitter, sour, slightly cold, liver, spleen, with nourishing and regulating menstruation, yin and yin, soft liver and pain, calming liver and yang, attending blood deficiency and chlorosis, irregular menstruation, Self-sweat, night sweats, hypochondriac pain, abdominal pain, limb pain, dizziness and dizziness.
[0047] 熟地黄: 味甘, 性微温, 入肝、 肾经, 具有补血滋阴, 益精填髓的功效, 主治 血虚萎黄; 眩晕, 心悸, 失眠, 月经不调, 崩不止; 肝肾阴亏, 盗汗, 足膝疼 痛, 腰膝酸软, 耳鸣耳聋, 头目昏花; 遗精阳痿; 不育不孕; 月经不调; 崩漏 下血; 须发早白; 消渴; 便秘; 肾虚喘促等证。  [0047] Rehmannia glutinosa: sweet, sexually lukewarm, into the liver, kidney, with blood and nourishing yin, Yijing fill the effect of the marrow, attending blood deficiency and chlorosis; dizziness, palpitations, insomnia, irregular menstruation, collapse; liver and kidney Yin deficiency, night sweats, pain in the feet and knees, weak waist and knees, tinnitus and deafness, head fainting; nocturnal impotence; infertility; irregular menstruation; blood leaking; early white; thirst; constipation; kidney deficiency and asthma .
[0048] 川芎: 味辛, 性温, 归肝、 胆、 心包经, 具有活血行气, 祛风止痛的功效, 主 治月经不调; 经闭痛经; 产后瘀滞腥痛; 症瘕肿块; 胸胁疼痛; 头痛眩晕; 风 寒湿痹; 跌打损伤; 痈疽疮疡等证。  [0048] Chuanxiong: Weixin, sexual temperature, liver, gallbladder, pericardium, with blood circulation, phlegm and pain relief, attending irregular menstruation; menstrual dysmenorrhea; postpartum stagnation pain; sputum mass; chest Threat pain; headache and dizziness; wind and cold dampness; bruises; hemorrhoids and other evidence.
[0049] 阿胶: 味甘、 性平, 入肺、 肝、 肾经, 有补血止血, 滋阴润燥的作用, 可用于 各种虚劳症状, 尤其是血虚之面色萎黄, 痩弱乏力, 头目晕眩, 心悸失眠; 营 养不良性贫血, 血小板减少性紫癜; 虚损性咳血; 吐血尿血便血; 阴虚肺燥之 咳嗽咽干, 痰中带血; 邪热久羁、 阴虚血耗、 虚风内动之筋脉拘急、 手足抽搐 等症。  [0049] Ejiao: sweet, flat, into the lungs, liver, kidney, have blood and stop bleeding, nourishing yin and moisturizing effect, can be used for a variety of symptoms of fatigue, especially the complexion of blood deficiency, sallow, weak and weak, Head stun, palpitations and insomnia; malnutrition anemia, thrombocytopenic purpura; septic hemoptysis; vomiting blood and blood in the stool; yin deficiency and lung dry cough and pharyngeal dryness, sputum with blood; evil heat for a long time, yin deficiency blood consumption In the virtual wind, the veins are in a hurry, and the hands and feet are convulsive.
[0050] 人参: 味甘、 微苦, 性微温, 入心、 肺、 脾经, 有大补元气, 补气益肺, 生津 止渴, 安神益智等功效, 既为救脱扶危之良剂, 亦为疗虚劳内伤之第一要药, 凡一切气血不足之证皆可应用, 主治劳伤虚损、 食少、 倦怠、 反胃吐食、 大便 滑泄、 虚咳喘促、 自汗暴脱、 惊悸、 健忘、 眩晕头痛、 阳痿、 尿频、 消渴、 妇 女崩漏、 小儿慢惊及久虚不复等证。  [0050] Ginseng: sweet, slightly bitter, sexually lukewarm, into the heart, lungs, spleen, have a great vitality, qi and Yifei, Shengjinzhike, Anshen puzzle and other effects, not only for the rescue and relief The agent is also the first medicine for treating internal injuries. All the evidences of deficiency of blood can be applied. Indications for fatigue, loss of food, fatigue, nausea, diarrhea, diarrhea, and cough Sweat violent, convulsions, forgetfulness, dizziness, headache, impotence, frequent urination, thirst, uterine bleeding, pediatric slowness and long absences.
[0051] 黄芪: 名 astragali radix, 味甘, 性温, 入脾、 肺经, 有补益脾土, 升举阳 气、 固表止汗, 托疮生肌等功效, 主要用于脾肺气虚所致之乏力食少便溏, 心 悸气短, 中气下陷之脏器下垂, 气不摄血之崩漏便血, 久泻脱肛; 表虚不固之 自汗盗汗, 气血不足等证。  [0051] Astragalus: name astragali radix, sweet, warm, into the spleen, lung, have beneficial spleen, lift yang, solid table antiperspirant, sore muscles and other effects, mainly used for spleen and lung qi deficiency Caused by lack of energy, less food, shortness of breath, shortness of breath, sag of the sag of the gas, stagnation of the blood without blood, long-term diarrhea, rectal prolapse, self-perspiration, night sweats, lack of blood and other evidence.
[0052] 党参: 味甘, 性平, 入肺、 脾经, 有补气益脾, 养血生津的作用, 主要用于脾 肺气虚或气血两虚之倦怠乏力、 气短, 咳嗽自汗等症状, 党参长于补脾养胃, 调理中焦, 兼有养血的作用, 其性平, 健脾运而不燥; 滋味阴而不湿, 能够改 善机体的免疫状态, 提高抗病能力, 促进消化吸收, 提高新陈代谢。 [0052] Codonopsis pilosula: sweet, flat, into the lungs, spleen, have qi and spleen, nourishing blood and fluid, mainly used for spleen and lung qi deficiency or qi and blood deficiency, fatigue, shortness of breath, cough, spontaneous sweating, etc. Symptoms, the party's ginseng in the spleen and stomach, conditioning the coke, and have the role of nourishing blood, its sexuality, spleen and transport is not dry; taste yin but not wet, can change Improve the immune status of the body, improve disease resistance, promote digestion and absorption, and improve metabolism.
[0053] 炙甘草: 味甘, 性平, 入十二经, 调和药性, 祛痰止咳的作用, 并能健脾和中 [0053] Zhigancao: sweet, flat, into the twelve classics, to reconcile the drug, to relieve cough, and to strengthen the spleen and
, 缓急止痛, 主要用于补脾益气, 清热解毒, 祛痰止咳, 缓急止痛, 调和诸药 , relieve pain, mainly used to replenish spleen and replenish qi, clearing away heat and detoxification, relieving cough, relieving pain, reconciling various medicines
[0054] 大枣: 了名 jujubaefmct , 味甘, 性温, 归脾、 胃经, 具有补脾和胃, 益 气生津, 调营卫, 解药毒的功效, 主治胃虚食少, 脾弱便溏, 气血津液不足, 营卫不和, 心悸怔忡。 妇人赃躁等证。 [0054] jujube: the name jujubaefmct, sweet, warm, spleen, stomach, with spleen and stomach, Yiqi Shengjin, adjust the camp Wei, antidote to the effect of drugs, attending stomach deficiency, less spleen Note, lack of blood and fluid, camp and peace, heart palpitations. The woman is waiting for the card.
[0055] 浮小麦: 拉丁名 Gramim^e , 性凉, 味甘咸, 功效止虚汗, 养心安神。 用于体 虚多汗, 脏躁症。 禁忌阴阳两虚所致的自汗盗汗者不宜用。 [0055] Floating wheat: Latin name Gramim^e, cool, sweet and salty, effective anti-sweat, nourish the heart and soothe the nerves. For physical and sweaty, viscera. It is not appropriate to use self-perspiration and night sweats caused by yin and yang deficiency.
[0056] 法半夏: 味辛、 性温, 归脾、 胃、 肺经, 具有燥湿化痰的功效, 主治痰多咳嗽[0056] French Pinellia: Weixin, sexual temperature, spleen, stomach, lung, with the effect of dampness and phlegm, attending more cough
, 风痰眩晕, 痰厥头痛等证。 , wind, dizziness, headache and other evidence.
[0057] 胆南星: 味苦、 微辛, 性凉, 归肺、 肝、 脾经, 具有清热化痰, 息风定惊的功 效, 用于痰热咳嗽, 咯痰黄稠, 中风痰迷, 癫狂惊痫等证。 [0057] Gallic star: bitter, slightly pungent, cool, return to the lungs, liver, spleen, with heat and phlegm, the effect of the wind and wind, used for hot cough, phlegm yellow thick, stroke fascinated, Epilepsy and other evidence.
[0058] 陈皮: 性温, 味辛、 苦; 归脾、 肺经, 辛散通温, 气味芳香, 长于理气, 能入 脾肺, 故既能行散肺气壅遏, 又能行气宽中, 用于肺气拥滞、 胸膈痞满及脾胃 气滞、 脘腹胀满等证。 [0058] Chenpi: Sexual temperature, Weixin, bitterness; return to the spleen, lung, spleen and warm, smelly, longer than qi, can enter the spleen and lungs, so it can not only disperse the lungs, but also the width In the case of lung gas stagnation, chest fullness and spleen and stomach stagnation, abdominal distension and other evidence.
[0059] 柴胡: 拉了名 bupleuri mdix , 为伞形科植物柴胡或狭叶柴胡的干燥根, 性微寒 [0059] Bupleurum: pulled the name bupleuri mdix, the dry root of the umbelliferous plant Bupleurum or Bupleurum chinense, slightly cold
、 味苦、 辛、 归肝经、 胆经, 具有散热、 杀菌的功效, 主治感冒发热、 寒热往 来、 疟疾, 肝郁气滞, 胸肋胀痛, 脱肛, 子宫脱落, 月经不调等证。 It has the functions of heat dissipation and sterilization, and it has the functions of heat dissipation and bactericidal treatment. It treats cold, fever, cold and heat, malaria, liver qi stagnation, chest rib pain, rectal prolapse, uterine shedding, irregular menstruation and so on.
[0060] 郁金: 味辛、 苦, 性寒, 归肝、 心、 肺经, 具有行气化瘀, 清心解郁, 利胆退 黄的功效, 主治经闭痛经,胸腹胀痛、 刺痛, 热病神昏, 癫痫发狂, 黄疸尿赤等 证。 [0060] turmeric: Weixin, bitter, cold, liver, heart, lung, with the effect of gasification, clear heart and stagnation, spleen and yellowing, attending menstrual dysmenorrhea, chest and abdomen pain, tingling , fever, fainting, epilepsy, jaundice, urinary red and other evidence.
[0061] 黄花菜: T名 Hemerocallis citrina Baroni , 性味甘凉, 有止血、 消炎、 清热 [0061] Daylily: T name Hemerocallis citrina Baroni, sweet and cool, with hemostasis, anti-inflammatory, heat
、 利湿、 消食、 明目、 安神等功效, 对吐血、 大便带血、 小便不通、 失眠、 乳 汁不下等有疗效。 , Lee dampness, digestion, eyesight, soothe the nerves and other effects, for vomiting blood, stool blood, urinary dysfunction, insomnia, breast milk, etc. have curative effect.
[0062] 茯神木: 味甘, 性平, 具有平肝安神的功效, 主治惊悸健忘, 中风不语, 脚气 转筋等证。  [0062] 茯神木: Sweet, flat, with the effect of calming the liver and soothe the nerves, attending convulsions and forgetfulness, strokes, speech, and athlete's foot.
[0063] 首乌藤: 味甘, 性平, 归心、 肝经, 具有养血安神, 祛风通络的功效, 主治失 眠多梦, 血虚身痛, 风湿痹痛; 皮肤瘙痒等证。 [0063] Shouwu vine: sweet, flat, heart, liver, with nourishing blood and soothe the nerves, the effect of phlegm and blood circulation, the main treatment Sleep more dreams, bloody body pain, rheumatism and pain; skin itching and other evidence.
[0064] 远志: 味苦、 辛, 性微温, 归心、 肾、 肺经, 具有安神益智, 祛痰, 消肿的功 效, 用于心肾不交引起的失眠多梦, 健忘惊悸, 神志恍惚, 咳痰不爽, 疮疡肿 毒, 乳房肿痛等证。  [0064] Yuanzhi: taste bitter, Xin, sexual lukewarm, heart, kidney, lung, with the effect of soothe the nerves, phlegm, swelling, for insomnia caused by heart and kidney, dreams, forgetfulness, sorrow , Cough is not good, sore swollen poison, breast swelling and so on.
[0065] 所述中药制剂的原料药经过提取获得浸膏后, 将浸膏与药学上可接受的载体或 稀释剂混合, 制备成制剂, 所述制剂的剂型优选为片剂、 胶囊剂、 颗粒剂、 丸 齐 ij、 口服液或注射剂, 所述注射剂为注射液、 注射用混悬液、 冻干粉针。  [0065] After the raw material medicine of the traditional Chinese medicine preparation is extracted to obtain an extract, the extract is mixed with a pharmaceutically acceptable carrier or diluent to prepare a preparation, and the dosage form of the preparation is preferably a tablet, a capsule, or a granule. The agent, the pills, the oral solution or the injection, the injection is an injection, a suspension for injection, and a lyophilized powder.
[0066] 所述药学上可接受的载体或稀释剂选自填充剂、 崩解剂、 粘合剂、 润滑剂、 矫 味剂、 渗透压调节剂或表面活性剂中的一种或几种。  The pharmaceutically acceptable carrier or diluent is one or more selected from the group consisting of a filler, a disintegrant, a binder, a lubricant, a flavoring agent, an osmotic pressure adjusting agent, or a surfactant.
[0067] 临床上气血不足证型的广泛性焦虑症患者, 虽然为气血不足的体征, 但是其临 床发病吋多惊恐不安、 伴性急多言、 甚则躁狂、 头昏、 头痛, 根据, 因临床实 践中精神病类患者虽然常采取口服给药, 但是发病吋, 却不能很好的配合药物 治疗, 采取口服等给药方式存在一定的困难, 因此优选采用注射液。  [0067] Patients with generalized anxiety disorder with qi and blood deficiency syndrome, although they are signs of qi and blood deficiency, but their clinical onset is more horrified, accompanied by irritability, even mania, dizziness, headache, according to Because the psychiatric patients in clinical practice often take oral administration, but the onset of sputum, but can not be well coordinated with drug treatment, there are certain difficulties in taking oral and other modes of administration, so it is preferred to use injection.
[0068] 本发明还提供了上述药物的制备方法, 其包括:  [0068] The present invention also provides a method for preparing the above-mentioned medicament, which comprises:
[0069] 第一步, 将各原料药分别碎成粗粉, 混合在一起, 加入相对于混合物质量 1〜2 倍的醇浓度为 80%的乙醇, 润湿 12小吋, 随后装柱进行渗漉, 渗漉液为醇浓度为 80%的乙醇, 使用的乙醇量为混合物质量的 15〜20倍, 渗漉速度 5ml.min - i.kg -i , 收集渗漉液, 减压浓缩至 65°C吋相对密度为 1.25〜1.30的浸膏;  [0069] In the first step, each raw material drug is separately pulverized into coarse powder, mixed together, and ethanol having an alcohol concentration of 80% relative to the mass of the mixture is added, and the mixture is wet for 12 hours, and then packed into a column for infiltration.漉, the percolate is ethanol with an alcohol concentration of 80%, the amount of ethanol used is 15 to 20 times the mass of the mixture, the percolation rate is 5 ml.min - i.kg -i , the percolate is collected, and concentrated under reduced pressure to 65 An extract having a relative density of 1.25 to 1.30;
[0070] 第二步, 将第一步获得浸膏按照 1:1的体积比加入醇浓度为 80%的乙醇, 2〜5°C 冷藏静置 24〜48小吋, 过滤除掉沉淀; 滤液减压回收, 获得干膏, 粉碎成粉末 , 加注射用水至所需制剂体积的 80%, 加入注射级活性炭, 加热至微沸并保持 10 〜30分钟搅拌, 过滤除掉活性炭, 加注射用水至所需制剂体积的 100%; 次经 0.2 2μηι的滤膜过滤, 调节滤液温度至 30°C〜50°C, 用截留分子量 8000〜30000的超 滤膜, 在压力为 0.05〜0.3MPa下进行超滤, 超滤液经灌封、 灭菌、 包装。  [0070] In the second step, the first step of obtaining the extract is added to the ethanol having an alcohol concentration of 80% in a volume ratio of 1:1, and is kept at a temperature of 2 to 5 ° C for 24 to 48 hours, and the precipitate is removed by filtration; Recover under reduced pressure, obtain dry paste, pulverize into powder, add water for injection to 80% of the required preparation volume, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 10~30 minutes, remove activated carbon by filtration, add water for injection to 100% of the required volume of the preparation; filtered through a 0.2 2 μηι filter, adjusting the temperature of the filtrate to 30 ° C to 50 ° C, using an ultrafiltration membrane with a molecular weight cut off of 8000 to 30000, at a pressure of 0.05 to 0.3 MPa. Filtration, ultrafiltrate is potted, sterilized, packaged.
[0071] 以下采用实施例来详细说明本发明的实施方式, 借此对本发明如何应用技术手 段来解决技术问题, 并达成技术效果的实现过程能充分理解并据以实施。  DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, embodiments of the present invention will be described in detail by way of embodiments, in which the present invention can be applied to the technical problems, and the implementation of the technical effects can be fully understood and implemented.
[0072] 实施例 1注射液 1  Example 1 Injection 1
[0073] 将酸枣仁 30g、 当归 35g、 白芍 30g、 熟地黄 25g、 川芎 25g、 阿胶 30g、 人参 40g 、 黄芪 40g、 党参 30g、 炙甘草 20g、 大枣 20g、 浮小麦 10g、 法半夏 15g、 胆南星 1 0g、 陈皮 20g、 柴胡 20g、 郁金 25g、 黄花菜 15g、 茯神木 20g、 首乌藤 25g和远志 1 Og碎成粗粉, 混合在一起, 加入 600g的醇浓度为 80%的乙醇, 润湿 12小吋, 随后 装柱进行渗漉, 渗漉液为醇浓度为 80%的乙醇, 使用的乙醇量为 7.5kg, 渗漉速 度 Sml.min kg -1 , 收集渗漉液, 减压浓缩至 65°C吋相对密度为 1.30的浸膏, 获 得的浸膏按照 1: 1的体积比加入醇浓度为 80%的乙醇, 2〜5°C冷藏静置 48小吋, 过滤除掉沉淀; 滤液减压回收, 获得干膏, 粉碎成粉末, 加注射用水至所需制 剂体积的 80%, 加入注射级活性炭, 加热至微沸并保持 30分钟搅拌, 过滤除掉活 性炭, 加注射用水至所需制剂体积的 100%; 次经 0.22μηι的滤膜过滤, 调节滤液 温度至 30°C〜50°C, 用截留分子量 30000的超滤膜, 在压力为 0.05MPa下进行超 滤, 超滤液经灌封、 灭菌、 包装。 [0073] 30g of Suanzaoren, Angelica 35g, Angelica 30g, Radix Rehmanniae 25g, Chuanxiong 25g, Ejiao 30g, Ginseng 40g , Astragalus 40g, Codonopsis pilosula 30g, Zhigancao 20g, Jujube 20g, Floating Wheat 10g, French Pinellia 15g, Dannan Star 10g, Chenpi 20g, Bupleurum 20g, Yujin 25g, Daylily 15g, Yushen 20g, Shouwu Rattan 25g and Polygala 1 Og are crushed into coarse powder, mixed together, 600g of ethanol with 80% alcohol concentration, wetted for 12 hours, and then packed into a column for percolation. The percolate is ethanol with an alcohol concentration of 80%. The amount of ethanol used was 7.5 kg, the percolation rate was Sml.min kg -1 , the percolate was collected, and the extract was concentrated under reduced pressure to a extract having a relative density of 1.30 at 65 ° C. The obtained extract was in a volume of 1:1. Compared with ethanol with 80% alcohol concentration, chilled at 2~5 °C for 48 hours, the precipitate was removed by filtration; the filtrate was recovered under reduced pressure to obtain a dry paste, which was pulverized into powder, and water for injection was added to the required volume of 80. %, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 30 minutes, remove activated carbon by filtration, add water for injection to 100% of the required preparation volume; filter through 0.22μηι filter, adjust the filtrate temperature to 30 °C ~50 ° C, with an ultrafiltration membrane with a molecular weight cut off of 30,000, at a pressure of 0.05 MPa Ultrafiltration is carried out, and the ultrafiltrate is potted, sterilized, and packaged.
[0074] 实施例 2注射液 2 Example 2 Injection 2
[0075] 将酸枣仁 30g、 当归 35g、 白芍 25g、 熟地黄 25g、 川芎 20g、 阿胶 25g、 人参 35g 、 黄芪 35g、 党参 30g、 炙甘草 15g、 大枣 15g、 浮小麦 10g、 法半夏 15g、 胆南星 1 0g、 陈皮 15g、 柴胡 20g、 郁金 20g、 黄花菜 15g、 茯神木 20g、 首乌藤 25g和远志 1 Og碎成粗粉, 混合在一起, 加入 600g的醇浓度为 80%的乙醇, 润湿 12小吋, 随后 装柱进行渗漉, 渗漉液为醇浓度为 80%的乙醇, 使用的乙醇量为 7.5kg, 渗漉速 度 5ml.min -i.kg -i, 收集渗漉液, 减压浓缩至 65°C吋相对密度为 1.30的浸膏, 获 得的浸膏按照 1: 1的体积比加入醇浓度为 80%的乙醇, 2〜5°C冷藏静置 48小吋, 过滤除掉沉淀; 滤液减压回收, 获得干膏, 粉碎成粉末, 加注射用水至所需制 剂体积的 80%, 加入注射级活性炭, 加热至微沸并保持 30分钟搅拌, 过滤除掉活 性炭, 加注射用水至所需制剂体积的 100%; 次经 0.22μηι的滤膜过滤, 调节滤液 温度至 30°C〜50°C, 用截留分子量 30000的超滤膜, 在压力为 0.05MPa下进行超 滤, 超滤液经灌封、 灭菌、 包装。  [0075] 30g of Suanzaoren, Angelica 35g, Angelica 25g, Radix Rehmanniae 25g, Chuanxiong 20g, Ejiao 25g, Ginseng 35g, Astragalus 35g, Codonopsis 30g, Zhigancao 15g, Jujube 15g, Floating Wheat 10g, French Pinellia 15g , Jinanxing 10g, dried tangerine peel 15g, Bupleurum 20g, turmeric 20g, day lily 15g, 茯神木20g, Shouwu vine 25g and Yuanzhi 1 Og broken into coarse powder, mixed together, adding 600g of alcohol concentration is 80% Ethanol, wet for 12 hours, and then packed into a column for percolation. The percolate is ethanol with an alcohol concentration of 80%, the amount of ethanol used is 7.5 kg, and the percolation rate is 5 ml.min -i.kg -i, collected. The percolate was concentrated under reduced pressure to an extract having a relative density of 1.30 at 65 ° C. The obtained extract was added with ethanol having an alcohol concentration of 80% in a volume ratio of 1:1, and kept at a temperature of 2 to 5 ° C for 48 hours.吋, remove the precipitate by filtration; recover the filtrate under reduced pressure, obtain a dry paste, pulverize into a powder, add water for injection to 80% of the volume of the desired preparation, add injection-grade activated carbon, heat to a slight boiling and keep stirring for 30 minutes, remove by filtration Activated carbon, water for injection to the required preparation 100% by volume; filtered through a 0.22μηι filter, adjusting the filtrate temperature to 30 ° C ~ 50 ° C, using ultrafiltration membrane with molecular weight cut off of 30000, ultrafiltration at a pressure of 0.05 MPa, ultrafiltrate irrigation Sealed, sterilized, packaged.
[0076] 实施例 3注射液 3  Example 3 Injection 3
[0077] 将酸枣仁 35g、 当归 40g、 白芍 30g、 熟地黄 30g、 川芎 25g、 阿胶 30g、 人参 40g 、 黄芪 40g、 党参 35g、 炙甘草 20g、 大枣 20g、 浮小麦 15g、 法半夏 20g、 胆南星 1 5g、 陈皮 20g、 柴胡 25g、 郁金 25g、 黄花菜 20g、 茯神木 25g、 首乌藤 30g和远志 1 5g碎成粗粉, 混合在一起, 加入 600g的醇浓度为 80%的乙醇, 润湿 12小吋, 随后 装柱进行渗漉, 渗漉液为醇浓度为 80%的乙醇, 使用的乙醇量为 7.5kg, 渗漉速 度 5ml.min -i.kg -i, 收集渗漉液, 减压浓缩至 65°C吋相对密度为 1.30的浸膏, 获 得的浸膏按照 1: 1的体积比加入醇浓度为 80%的乙醇, 2〜5°C冷藏静置 48小吋, 过滤除掉沉淀; 滤液减压回收, 获得干膏, 粉碎成粉末, 加注射用水至所需制 剂体积的 80%, 加入注射级活性炭, 加热至微沸并保持 30分钟搅拌, 过滤除掉活 性炭, 加注射用水至所需制剂体积的 100% ; 次经 0.22μηι的滤膜过滤, 调节滤液 温度至 30°C〜50°C, 用截留分子量 30000的超滤膜, 在压力为 0.05MPa下进行超 滤, 超滤液经灌封、 灭菌、 包装。 [0077] 35g of Suanzaoren, Angelica 40g, Angelica 30g, Radix Rehmanniae 30g, Chuanxiong 25g, Ejiao 30g, Ginseng 40g, Astragalus 40g, Codonopsis 35g, Zhigancao 20g, Jujube 20g, Floating Wheat 15g, French Pinelli 20g , biliary star 1 5g, dried tangerine peel 20g, Bupleurum 25g, turmeric 25g, day lily 20g, 茯神木25g, Shouwu vine 30g and Yuanzhi 1 5g was crushed into coarse powder, mixed together, 600g of ethanol with 80% alcohol concentration was added, wetted for 12 hours, and then packed into a column for percolation. The percolate was ethanol with an alcohol concentration of 80%, and the amount of ethanol used. For 7.5 kg, the percolation rate was 5 ml.min -i.kg -i, the percolate was collected, and concentrated under reduced pressure to 65 ° C. The relative density of 1.30 was obtained. The obtained extract was added in a volume ratio of 1:1. Ethanol with an alcohol concentration of 80%, chilled at 2 to 5 ° C for 48 hours, and the precipitate was removed by filtration; the filtrate was recovered under reduced pressure to obtain a dry paste, which was pulverized into powder, and water for injection was added to 80% of the desired preparation volume. Add injection-grade activated carbon, heat to a slight boiling and keep stirring for 30 minutes, remove activated carbon by filtration, add water for injection to 100% of the required preparation volume; filter through 0.22μηι filter, adjust the temperature of the filtrate to 30 °C~50 °C, ultrafiltration was carried out with an ultrafiltration membrane with a molecular weight cut off of 30000 at a pressure of 0.05 MPa, and the ultrafiltrate was potted, sterilized, and packaged.
[0078] 实施例 4毒性检测  Example 4 Toxicity Test
[0079] 急毒性试验  Acute toxicity test
[0080] 实验动物: 豚鼠, 雌雄各半, 体重 300~400g (普通级) , 动物分笼饲养, 对每 只动物进行编号和称重, 检疫观察 3d后进行实验。 对实验动物进行外观体征、 行为活动、 摄食量和体重观察。 饲养环境, 室温 19~26°C, 日温差≤4°C, 相对湿 度 ^ Ο^, 昼夜明暗交替吋间 12h/12h。  [0080] Experimental animals: Guinea pig, male and female, weighing 300-400 g (common grade), animals were kept in cages, each animal was numbered and weighed, and the experiment was carried out 3 days after quarantine observation. Subject animals were observed for appearance signs, behavioral activities, food intake and body weight. Breeding environment, room temperature 19~26°C, daily temperature difference ≤4°C, relative humidity ^ Ο^, day and night light and dark alternately 12h/12h.
[0081] 实验药品  Experimental drug
[0082] 卵白蛋白: 华英生物技术有限公司  [0082] Ovalbumin: Huaying Biotechnology Co., Ltd.
[0083] 本发明实施例 1制备的中药注射液 1, 处理成高纯度中药注射液 20ml (对应原 药量为 435g) , 相当于本发明中药制剂高纯度的注射液含生药 21.75g/ml, 按照 0. 75ml/kg体重注射给药, 4°C保存备用, 使用吋恢复至湿温。  The traditional Chinese medicine injection 1 prepared in the first embodiment of the present invention is processed into a high-purity traditional Chinese medicine injection solution of 20 ml (corresponding to the original drug amount of 435 g), which is equivalent to the high-purity injection of the traditional Chinese medicine preparation containing the crude drug 21.75 g/ml. The drug was administered by injection at 0. 75 ml/kg body weight, stored at 4 ° C for use, and returned to wet temperature using hydrazine.
[0084] 方法  Method
[0085] 主动全身过敏试验: 取豚鼠 60只, 随机分为 5组, 每组 12只: 阳性对照组 (卵 白蛋白 3mg/只) 、 阴性对照组 (0.9%氯化钠注射液) 、 本发明中药制剂注射液 高剂量组 0.75ml/kg、 中剂量组 0.5ml/kg、 低剂量组 0.25ml/kg。 各组豚鼠腹腔注 射给药致敏, 隔日 1次, 共 5次。 末次致敏后第 14天豚鼠后肢小隐静脉注射给药 激发, 激发剂量为致敏剂量的 2倍。 致敏期间每日观察动物症状, 初次、 末次致 敏和激发当日测定动物体重。 激发后详细观察 30min内每只动物的反应、 症状出 现及消失吋间, 如果给药组动物出现过敏反应症状则需延长观察吋间至 3h。 观 察、 记录过敏反应发生程度并计算过敏反应发生率。 根据过敏反应发生率和发 生程度进行综合判断。 药物组若出现过敏反应, 取健康未致敏豚鼠 2只, 静脉注 射致敏剂量的药物, 观察有无类过敏反应症状。 Active systemic allergy test: 60 guinea pigs were randomly divided into 5 groups, 12 rats in each group: positive control group (ovalbumin 3 mg/only), negative control group (0.9% sodium chloride injection), the present invention The high-dose group of Chinese medicine preparation injection was 0.75ml/kg, the middle dose group was 0.5ml/kg, and the low-dose group was 0.25ml/kg. Each group of guinea pigs was sensitized by intraperitoneal injection, once every other day for 5 times. On the 14th day after the last sensitization, the guinea pig hind limbs were administered with saphenous vein injection, and the challenge dose was twice the sensitizing dose. Animal symptoms were observed daily during sensitization, and animal weight was measured on the first, last sensitization, and challenge day. After the challenge, the response, symptoms, and disappearance of each animal within 30 minutes were observed in detail. If the allergic reaction symptoms appeared in the animals in the administration group, the observation period should be extended to 3 hours. View Investigate, record the extent of allergic reactions and calculate the incidence of allergic reactions. Comprehensive judgment based on the incidence and degree of allergic reactions. In the drug group, if there is an allergic reaction, take 2 healthy sensitized guinea pigs, and administer a sensitizing dose of the drug to observe the symptoms of allergic reactions.
[0086] 结果 [0086] Results
[0087] 给药组动物活动及进食等一般状况未见明显异常, 各组豚鼠的体重变化未见明 显差异。 静脉给药激发后, 阳性对照组的所有 7只豚鼠多数出现搔鼻、 咳嗽、 排 尿、 痉挛、 横转后在 l~5min死亡, 过敏反应发生率 100% ; 其余组动物未发现过 敏反应症状, 过敏反应发生率均为 0%, 表明在该实验条件下本发明中药制剂注 射液未引起豚鼠主动全身过敏反应。 现代药理学研究认为, 动物给药剂量为人 体正常给药剂量 100倍以上而无毒副作用发生吋, 其使用是安全的, 本发明中药 制剂注射液高中低剂量组, 给药剂量分别是 0.467ml、 0.175ml、 0.0875ml, 对 应的原中药量为 10.15725g、 3.80625g、 1.903125g, 是正常人体每 kg给药的 140.1 倍、 52.5倍、 26.25倍 (正常人体每 kg给药为 0.0725g) , 因此可以证明, 本发明 中药制剂注射液是安全的, 因此可以间接证明其他剂型的安全性。  [0087] There was no significant abnormality in the general conditions of activity and eating of the animals in the drug-administered group, and there was no significant difference in body weight changes of the guinea pigs in each group. After induction by intravenous administration, most of the 7 guinea pigs in the positive control group died of sputum, cough, urination, sputum, and sinus lapsed for 1 to 5 minutes, and the incidence of allergic reaction was 100%. The other groups showed no allergic reaction symptoms. The incidence of allergic reaction was 0%, indicating that the traditional Chinese medicine preparation injection of the present invention did not cause an active systemic allergic reaction in guinea pigs under the experimental conditions. According to modern pharmacological research, the dose of animal is 100 times or more of the normal dose of the human body, and no toxic side effects occur. The use of the traditional Chinese medicine preparation injection is high, medium and low dose, and the dosage is 0.467ml. 0.175ml, 0.0875ml, corresponding to the original Chinese medicine amount of 10.15725g, 3.80625g, 1.903125g, which is 140.1 times, 52.5 times, 26.25 times per kg of normal human body administration (0.0725g per kg of normal human body administration), Therefore, it can be proved that the injection of the traditional Chinese medicine preparation of the present invention is safe, and thus the safety of other dosage forms can be indirectly proved.
[0088] 长期毒性试验  Long-term toxicity test
[0089] 实验材料  [0089] Experimental material
[0090] 实验动物  Experimental animal
[0091] 新西兰大耳白家兔, 体重 2.0~3.0kg (普通级) , 对每只动物进行编号和称重, 检疫观察 3d后进行实验。 对实验动物进行外观体征、 行为活动、 摄食量和体重 观察。 饲养环境, 室温 19~26°C, 日温差≤4°C, 相对湿度 40<¾~70<¾, 昼夜明暗交 替吋间 12h/12h。  [0091] New Zealand white rabbits, weighing 2.0~3.0kg (common grade), numbered and weighed each animal, and conducted experiments after 3 days of quarantine observation. Subject animals were observed for appearance signs, behavioral activities, food intake and body weight. Breeding environment, room temperature 19~26 °C, daily temperature difference ≤ 4 °C, relative humidity 40<3⁄4~70<3⁄4, day and night light and dark alternately 12h/12h.
[0092] 实验药品  Experimental drug
[0093] 本发明中药实施例 1制备的注射液 1, 获取高纯度中药注射液 20ml, (对应原 药量为 435g) , 相当于本发明中药制剂高纯度的注射液含生药 21.75g/ml, 4°C保 存备用, 使用吋恢复至湿温。  The injection solution 1 prepared in the traditional Chinese medicine example 1 of the present invention obtains 20 ml of high-purity traditional Chinese medicine injection (corresponding to the original drug amount of 435 g), which is equivalent to the high-purity injection of the traditional Chinese medicine preparation containing 21.75 g/ml of the crude drug. Store at 4 °C for backup and use 吋 to return to wet temperature.
[0094] 血管刺激性试验  Vascular irritation test
[0095] 取正常的健康家兔 21只, 随机分为 3组, 即高、 中、 低剂量组 (本发明中药制 剂注射液 0.5ml/kg、 0.25ml/kg、 0.125ml/kg) , 家兔缘静脉左耳滴注上述药物, 右耳滴注等剂量 0.9%氯化钠注射液, 每天给药 1次, 连续 10d, 每天给药前以及 末次给药后 48h对动物和注射部位进行肉眼观察, 观察记录注射部位有无红肿、 充血等刺激现象。 末次给药后 48h每组处死半数动物, 以耳缘静脉注射点至向心 方向 (避幵注射部位) 2cm, 连续取 3段血管连同周围组织, 每段 lcm, 用 10%甲 醛溶液固定, 做病理组织学检査, 观察静脉血管组织有无炎症反应, 甚至变性 、 坏死等显著性刺激反应。 剩余动物继续观察 21d后再进行组织病理学检査, 以 了解刺激性反应的可逆性。 实验期间, 实验动物的左耳和右耳给药局部血管均 未见任何刺激反应症状, 刺激反应评分为 0分。 [0095] 21 normal healthy rabbits were randomly divided into 3 groups, namely, high, medium and low dose groups (the Chinese medicine preparation injection 0.5 ml/kg, 0.25 ml/kg, 0.125 ml/kg). Injecting the above drugs into the left ear of the rabbit vein, The right ear was instilled with an equal dose of 0.9% sodium chloride injection, once a day for 10 days, before the daily administration and 48 hours after the last administration, the animals and the injection site were visually observed to observe the presence or absence of redness at the injection site. Stimulation such as congestion. At the 48th hour after the last administration, half of the animals were sacrificed in each group. The ear vein was injected to the centripetal direction (avoiding the injection site) 2cm, and the three vessels were continuously taken along with the surrounding tissue. Each segment was fixed by 10% formaldehyde solution. Histopathological examination revealed venous vascular tissue with or without inflammatory response, and even significant stimuli such as degeneration and necrosis. The remaining animals were observed for 21 days before histopathological examination to understand the reversibility of the irritating response. During the experiment, no symptoms of irritation were observed in the left and right ear of the experimental animals, and the stimulation response score was 0.
[0096] 病理学检査结果显示给药结束及恢复期结束吋, 实验动物 0.9%氯化钠注射液对 照侧和高、 中、 低剂量组血管及周围组织均未见明显异常。 本次试验条件下, 家兔静脉注射给予本发明中药制剂注射液高、 中、 低剂量, 对注射部位无刺激 性。 [0096] The pathological examination showed that after the end of the administration and the end of the recovery period, there were no obvious abnormalities in the blood vessels and surrounding tissues of the control group and the high, medium and low dose groups of 0.9% sodium chloride injection. Under the conditions of this test, rabbits were given intravenously with high, medium and low doses of the traditional Chinese medicine preparation injection, and no irritation to the injection site.
[0097] 实施例 5临床研究  Example 5 Clinical Study
[0098] 一般资料 General information
[0099] 研究对象 [0099] Research object
[0100] 本研究病例均来自 2013年 8月 -2014年 11月, 神经内科门诊及住院病人, 共 298 例, 治疗组 162例, 对照组 136例。  [0100] The cases of this study were from August 2013 to November 2014. There were 298 outpatients and inpatients in neurology, 162 in the treatment group and 136 in the control group.
[0101] 研究方法 Research method
[0102] 根据简单、 随机、 平行对照的原则将所选病例分为治疗组及对照组, 以汉密尔 顿焦虑量表 (HAMA) 及自拟中医症候量表为标准评定患者服药前后症情变化 , 并对比治疗组 (本发明中药制剂) 与对照组 (黛力新) 临床疗效差异  [0102] According to the principle of simple, randomized, parallel control, the selected cases were divided into a treatment group and a control group, and the Hamilton anxiety scale (HAMA) and the self-made TCM symptom scale were used as criteria to assess the change of the patient before and after taking the drug, and Comparison of clinical efficacy between the control group (the Chinese medicine preparation of the invention) and the control group (黛力新)
[0103] 诊断标准  [0103] Diagnostic criteria
[0104] 西医诊断标准  Western diagnostic criteria
[0105] 按照 《中国精神疾病分类与诊断要点》 第三版 (CCND-3) 焦虑症诊断要点包 括症状标准、 严重标准、 病程标准和排除标准, 在符合神经症诊断要点的前提 下, 需符合这 4项标准诊断才能成立:  [0105] According to the "China Mental Disorders Classification and Diagnostic Points" Third Edition (CCND-3) The diagnostic criteria for anxiety disorders include symptom criteria, serious criteria, disease criteria and exclusion criteria, and must meet the criteria for diagnosis of neurosis. These four standard diagnoses can be established:
[0106] (1) 症状标准: 以持续的原发性焦虑症状为主, 并符合下列 2项: ①经常或持 续的无明确对象和固定内容的自觉难以控制的恐惧或提心吊胆; ②植物神经功能 紊乱或运动不安; [0106] (1) Symptom criteria: Mainly due to persistent primary anxiety symptoms, and meet the following two items: 1 Frequent or persistent consciously uncontrollable fear or fearlessness of clear objects and fixed content; 2 Autonomic function Disordered or uneasy;
[0107] (2) 严重标准 患者社会功能受损, 因难以忍受又无法解脱而感到痛苦; [0108] (3) 病程标准 符合上述症状标准至少已 6个月; [0107] (2) Severe criteria The patient's social function is impaired, and he feels painful because he is unbearable and unable to relieve; [0108] (3) The course of disease meets the above criteria for at least 6 months;
[0109] (4) 排除标准 排除躯体疾病继发性焦虑; 排除药物戒断反应, 其他精神疾 病继发性焦虑 [0109] (4) Exclusion criteria Exclusion of physical anxiety secondary anxiety; exclusion of drug withdrawal response, other mental illness secondary anxiety
[0110] 中医诊断标准 [0110] TCM Diagnostic Criteria
[0111] 参考 《中医病证诊断疗效标准》 郁病的诊断标准诊断依据 [0111] Reference "Diagnostic and therapeutic criteria for TCM syndromes" Diagnostic criteria for diagnosis of depression
[0112] (1) 优郁不畅, 精神不振, 胸闷胁胀, 善太息, 或不思饮食, 失眠多梦, 易 怒善哭等症; [0112] (1) poor stagnation, lack of energy, chest tightness, bloating, goodness, or not thinking about diet, insomnia, dreams, irritability, crying, etc.;
[0113] (2) 有郁怒、 多虑、 悲哀、 忧愁等情志所伤史;  [0113] (2) There is a history of anger, worry, sadness, sorrow, and so on;
[0114] (3) 经各系统检査和实验室检査可排除器质性疾病; [0114] (3) Organic diseases can be ruled out by various system examinations and laboratory tests;
[0115] (4) 应与癫病、 狂病鉴别 [0115] (4) should be differentiated from epilepsy, madness
[0116] 症候诊断标准  [0116] Symptom diagnostic criteria
[0117] 主证: (1) 清绪不宁 (2) 善思多虑 (3) 善恐不安  [0117] Main card: (1) Qing Xuan Yin (2) Good thinking and worry (3) Good fear and anxiety
[0118] 次证: (1) 头晕目眩、 面色苍白无华 (2) 自汗无力 (3) 失眠多梦 (4) 胸闷  [0118] Second card: (1) Dizziness, pale complexion (2) Self-sweat weakness (3) Insomnia and dreams (4) Chest tightness
(5) 心悸、 气短 (6) 舌淡、 脉弱  (5) palpitations, shortness of breath (6) pale tongue, weak pulse
[0119] 主证必备, 次证 (1) - (6) 具备 1项以上, 参考舌苔、 脉象即可诊断。  [0119] Required for the main card, sub-certificate (1) - (6) With more than one item, the tongue coating and pulse can be diagnosed.
[0120] 纳入标准  [0120] Inclusion criteria
[0121] (1) 符合 《中国精神疾病分类与诊断要点》 第三版 (CCMD-3) /焦虑症的诊 断标准; 汉密尔顿焦虑量表 (HAMA) 14项评分≥ 14分  [0121] (1) Comply with the Chinese Mental Disease Classification and Diagnosis Key Points Third Edition (CCMD-3) / Diagnostic criteria for anxiety disorders; Hamilton Anxiety Scale (HAMA) 14 scores ≥ 14 points
[0122] (2) 符合中医诊断标准 [0122] (2) Meet the diagnostic criteria of Chinese medicine
[0123] (3) 符合症候诊断标准 (3) Compliance diagnostic criteria
[0124] (4) 年齢在 18-65岁之间 (含 18岁、 65岁) (4) The age is between 18-65 years old (including 18 years old, 65 years old)
[0125] 排除标准  [0125] Exclusion criteria
[0126] (1) 严重心、 肝、 .肾疾患或严重器质性疾病患者;  (1) a patient with severe heart, liver, kidney disease or severe organic disease;
[0127] (2) 抑郁症、 继发性焦虑患者; (2) depression, secondary anxiety patients;
[0128] (3) 药物依赖、 酗酒者; (3) drug dependence, alcoholics;
[0129] (4) 严重自杀倾向者; [0130] (5) 哺乳期、 妊娠期妇女。 (4) a serious suicidal tendency; (5) Lactating, pregnant women.
[0131] 治疗方法 Treatment method
[0132] 治疗组: 采用本发明实施例 1制备的中药制剂高纯度注射液 1, 20ml注射液加入 0.9%氯化钠配制成 lOOmT注射液, 静脉滴注, 100滴 /min, 每日注射一次, 疗程 为 4周。  [0132] The treatment group: using the Chinese medicine preparation prepared by the embodiment 1 of the present invention, the high-purity injection solution, 20 ml injection is added with 0.9% sodium chloride to prepare 100 mT injection, intravenous drip, 100 drops/min, once daily injection. The course of treatment is 4 weeks.
[0133] 对照组: 以黛力新 (氟哌噻吨美利曲辛片) 治疗, 服法: 1片每日, 每日清晨 服, 疗程为 4周 (黛力新由丹麦 H.Lundbeck生产, lO.smg/片, 20片 /盒) 。 氟哌噻 吨是一种噻吨类神经阻滞剂, 小剂量具有抗焦虑和抗抑郁作用, 美利曲辛是一 种双相抗抑郁剂, 低剂量应用吋, 具有兴奋特性, 两种成份的复方制剂具有抗 抑郁、 抗焦虑和兴奋特性。  [0133] Control group: treated with 黛力新 (flupirtine tamoxifen tablets), taking: 1 tablet daily, morning morning, 4 weeks of treatment (黛力新 produced by H.Lundbeck, Denmark) , lO.smg / piece, 20 pieces / box). Flutethiophene is a thioxanthine blocker with low-dose anti-anxiety and anti-depressant effects. Merlitexine is a biphasic antidepressant, low-dose sputum, excitatory, two components The combination has antidepressant, anxiolytic and excitatory properties.
[0134] 疗效观察指标  [0134] efficacy observation indicators
[0135] 汉密尔顿焦虑量表 (HAMA) 评分  Hamilton Anxiety Scale (HAMA) score
[0136] 中医症状分级量化标准  [0136] TCM symptom classification and quantification standard
[0137] 主证:  [0137] Main card:
[0138] (1) 情绪不宁  [0138] (1) Emotional restlessness
[0139] 0分: 没有或很少吋间; 1分: 小部分吋间: 2分: 相当多吋间; 3分: 绝大部分 或全部吋间  [0139] 0 points: No or very few days; 1 point: Small part of the day: 2 points: quite a lot of time; 3 points: Most or all of the daytime
[0140] (2) 善思多虑 [2140] (2) Thinking and thinking
[0141] 0分: 没有或很少吋间; 1分: 小部分吋间: 2分: 相当多吋间; 3分: 绝大部分 或全部吋间。  [0141] 0 points: No or very few days; 1 point: Small part of the day: 2 points: quite a lot of time; 3 points: Most or all of the time.
[0142] 次症:  [0142] Secondary disease:
[0143] (1) 头晕目眩 0分: 无 1分: 有  [0143] (1) Dizziness 0 points: None 1 point: Yes
[0144] (2) 心烦易怒 0分: 无 1分: 有  [0144] (2) Upset and irritable 0 points: None 1 point: Yes
[0145] (3) 失眠多梦 0分: 无 1分: 有  [0145] (3) Insomnia and more dreams 0 points: None 1 point: Yes
[0146] (4) 胸闷 0分: 无 1分: 有  [0146] (4) Chest tightness 0 points: None 1 point: Yes
[0147] (5) 心悸 0分: 无 1分: 有  [0147] (5) Heart palpitations 0 points: None 1 point: Yes
[0148] (6) 口干、 口苦 0分: 无 1分: 有  [0148] (6) Dry mouth, bitterness 0 points: None 1 point: Yes
[0149] 临床疗效评价 [0150] 汉密尔顿焦虑量表 (RAMA) 评分疗效判定标准 (治疗前及治疗第 2、 4周末各 评定一次) [0149] Clinical efficacy evaluation [0150] Hamilton anxiety scale (RAMA) score judgment criteria (pre-treatment and treatment at the 2nd and 4th weekend)
[0151] 减分率 = (治疗前总分-治疗后总分) /治疗前总分 χ100%  [0151] Subtraction rate = (total score before treatment - total score after treatment) / total score before treatment χ 100%
[0152] 痊愈: HAMA减分率) 75%;  [0152] Recovery: HAMA reduction rate) 75%;
[0153] 显著好转: HAMA减分率) 50%, 但<75<¾;  [0153] Significantly improved: HAMA reduction rate) 50%, but <75<3⁄4;
[0154] 进步: HAMA减分率多 30%, 但<50<¾;  [0154] Progress: HAMA reduction rate is 30% more, but <50<3⁄4;
[0155] 无效: HAMA减分率 <30<¾;  [0155] Invalid: HAMA reduction rate <30<3⁄4;
[0156] 有效率二痊愈 +显著好转 +进步。  [0156] Efficient two recovery + significantly improved + progress.
[0157] 中医症候疗效判定标准 (治疗前及治疗第 2、 4周末各评定一次)  [0157] TCM symptom evaluation criteria (measured before treatment and at the 2nd and 4th weekend of treatment)
[0158] 减分率 = (治疗前总分一治疗后总分) /治疗前总分 χ100%  [0158] Subtraction rate = (total score before treatment, total score after treatment) / total score before treatment χ 100%
[0159] 痊愈: 中医症候体征评分减分率) 90%;  [0159] Recovery: TCM syndrome sign score reduction rate) 90%;
[0160] 显著好转: 中医症候体征评分减分率) 70%, 但<90<¾;  [0160] Significantly improved: TCM symptom score score reduction rate) 70%, but <90<3⁄4;
[0161] 进步: 中医症候体征评分减分率多 30%, 但<70<¾;  [0161] Progress: TCM syndrome sign scores are reduced by 30%, but <70<3⁄4;
[0162] 无效: 中医症候体征评分减分率 <30%;  [0162] Invalid: TCM symptom score reduction rate <30%;
[0163] 有效率 =痊愈十显著好转 +进步。  [0163] Efficient = Healing 10 significantly improved + progress.
[0164] 不良反应  Adverse reactions
[0165] 研究过程中如出现不良反应, 应及吋记录, 并按如下标准判断不良反应程度: [0166] 轻度: 患者可忍受, 不影响治疗, 不需要特别处理, 对患者康复无影响;  [0165] If an adverse reaction occurs during the study, the sputum should be recorded, and the degree of adverse reaction should be judged according to the following criteria: [0166] Mild: The patient can tolerate, does not affect the treatment, does not require special treatment, and has no effect on the rehabilitation of the patient;
[0167] 中度: 患者难以忍受, 需要撤药中止研究或做特殊处理, 对患者康复有直接影 响; [0167] Moderate: The patient is unbearable and needs to withdraw the drug to stop the study or do special treatment, which has a direct impact on the rehabilitation of the patient;
[0168] 重度: 危及患者生命, 致死或致残, 需立即撤药或做紧急处理。  [0168] Severe: Endangering the patient's life, causing death or disability, requiring immediate withdrawal or emergency treatment.
[0169] 统计分析 Statistical analysis
[0170] 建立数据库 [0170] Establishing a database
[0171] 用 EXCel2013建立数据库, 内容包括: 姓名, 性别, 年齢, 病程, HAMA量表 积分及中医症候量表积分 (治疗前, 治疗 2、 4周后分别评定一次) 采用 SPSS17. 0统计软件进行统计分析和图形制作计数资料用频数和百分比表示; 计量资料用 均数、 标准差表示, 计数资料用 X2检验, 计量资料用 t检验 P<0.05认为有统计学 意义。 [0172] [0171] The database was established with E XC el2013, including: name, gender, age, duration of disease, HAMA scale score and TCM symptom scale score (pre-treatment, treatment after 2 and 4 weeks). SPSS 17. 0 statistics The software performs statistical analysis and graph production count data by frequency and percentage; the measurement data is expressed by mean and standard deviation, the count data is X2 test, and the measurement data is considered statistically significant by t test P<0.05. [0172]
[0173] 两组患者 HAMA积分比较 [0173] Comparison of HAMA scores between the two groups of patients
[0174] [0174]
Figure imgf000019_0001
Figure imgf000019_0001
翁鍾歲聰裏  Weng Zhong Sui Congli
Figure imgf000019_0002
不良反应观察结果
Figure imgf000019_0002
Adverse reaction observation
[0175] 4周治疗结束后两组患者均未见中重度不良反应, 治疗组有 5例患者在服药后出 现胃院不适, 经减量、 药物每日分 3次服用、 饭后服用后症状消失对照组 2例患 者服药后出现轻度便秘症状, 2例患者服药后出现口干症状, 停药后症状消失其 余未见明显不良反应。  [0175] After 4 weeks of treatment, there were no moderate to severe adverse reactions in the two groups. In the treatment group, 5 patients developed gastric discomfort after taking the drug. After the reduction, the drug was taken 3 times a day, and the symptoms after the meal were taken. In the disappeared control group, 2 patients developed mild constipation symptoms after taking the drug. Two patients developed dry mouth symptoms after taking the drug. After stopping the drug, the symptoms disappeared and no obvious adverse reactions were observed.
[0176] ΗΑΜΑ积分评定: 治疗 2周后, 中药与西药均起效, 两组差异不明显, 中药、 西药疗效相当; 治疗 4周后两组均有效, 且中药组疗效优于西药组。 [0177] 中医症候积分评定: 治疗 2周后, 中药组、 西药组积分均较治疗前下降, 两组 差异有统计学意义, 说明中药组疗效比西药组好; 治疗 4周后, 中药组疗效仍优 于西药组。 [0176] Evaluation of ΗΑΜΑ points: After 2 weeks of treatment, both Chinese medicine and western medicine were effective. The difference between the two groups was not obvious. The efficacy of traditional Chinese medicine and western medicine was equivalent. After 4 weeks of treatment, the two groups were effective, and the Chinese medicine group was better than the western medicine group. [0177] TCM syndrome score evaluation: After 2 weeks of treatment, the scores of the Chinese medicine group and the western medicine group were lower than those before treatment. The difference between the two groups was statistically significant, indicating that the efficacy of the Chinese medicine group was better than that of the western medicine group; after 4 weeks of treatment, the efficacy of the Chinese medicine group Still better than the Western Medicine Group.
[0178] 从不良反应方面看, 治疗过程中, 中药组无明显不良反应, 西药组偶有便秘、 口干等症状。  [0178] From the aspect of adverse reactions, there was no obvious adverse reaction in the Chinese medicine group during the treatment, and the western medicine group occasionally had symptoms such as constipation and dry mouth.
[0179] 总体来看, 中药组治疗 2周吋疗效稍优于西药组, 治疗 4周疗效明显好于西药组 , 差异具有统计学意义。  [0179] Overall, the efficacy of the Chinese medicine group was slightly better than that of the western medicine group in the treatment of 2 weeks, and the treatment was significantly better than the western medicine group in the 4 weeks. The difference was statistically significant.
[0180] HAMA量表积分评定及中医症候积分评定结果稍有差异, 治疗 2周吋 HAMA积 分评定中药组与西药组疗效相似, 而中医症候积分评定中药组疗效优于西药组 , 治疗 4周吋两评分标准结果相同, 均为中药组疗效优于西药组。 这可能是因为 中医症候量表主要观察患者的主观症状, 评定的重点与 HAMA量表不同, 因此 产生评定结论的差异。  [0180] The HAMA scale integral evaluation and the TCM syndrome score evaluation results were slightly different. The treatment of the HAMA score was similar to the Western medicine group in the 2 weeks after treatment, and the Chinese medicine group was better than the western medicine group in the treatment of 4 weeks. The results of the two scoring standards were the same, and the efficacy of the Chinese medicine group was better than that of the western medicine group. This may be because the TCM Symptom Scale mainly observes the subjective symptoms of the patients, and the assessment focuses on the HAMA scale, thus resulting in differences in assessment conclusions.
[0181] 综上所述, 本发明中药注射液治疗气血不足证型的广泛性焦虑症证具有显著疗 效, 短期疗效与黛力新相似, 长期疗效优于黛力新, 且无明显不良反应, 故认 为, 本发明中药制剂的治疗效果具有疗效持久, 不良反应少的特点, 且患者对 中药的接受度高于西药。  [0181] In summary, the traditional Chinese medicine injection has a remarkable curative effect on the generalized anxiety syndrome of the syndrome of deficiency of blood and blood, and the short-term curative effect is similar to that of the new force, and the long-term curative effect is superior to that of the new force, and no obvious adverse reaction. Therefore, it is considered that the therapeutic effect of the traditional Chinese medicine preparation of the invention has the characteristics of long-lasting effect and less adverse reactions, and the patient's acceptance of the traditional Chinese medicine is higher than that of the western medicine.
[0182] 实施例 6动物实验研究  Example 6 Animal Experimental Study
[0183] 实验动物  Experimental animal
[0184] 健康雄性 Wistar大鼠 60只, 体质量 130-150g。 动物于实验前 7d进入实验室以适 应环境。 室温 20±2°C, 湿度 50<¾〜70<¾。 大鼠均饲养于昼夜颠倒环境, 每日 20:00 幵灯, 8:00关灯。  [0184] 60 healthy male Wistar rats, weighing 130-150 g. Animals entered the laboratory 7 days prior to the experiment to suit the environment. Room temperature 20 ± 2 ° C, humidity 50 < 3⁄4 ~ 70 < 3⁄4. Rats were kept in a day and night environment, lit up at 20:00 daily, and turned off at 8:00.
[0185] 实验药物  Experimental drug
[0186] 本发明实施例 1制备的注射液 1 ; 地西泮片 (DXP) , 规格: 片剂, 每片 2.5mg Injectable solution 1 prepared in Example 1 of the present invention; diazepam (DXP), specification: tablet, 2.5 mg per tablet
, 国药准字 H37023039, 山东省平原制药厂出品, 制备成 0.5mg/ml水溶液。 , Chinese medicine Zhunzi H37023039, produced by Shandong Plain Pharmaceutical Factory, prepared into 0.5mg / ml aqueous solution.
[0187] 实验仪器 [0187] Experimental instrument
[0188] 大鼠旷场实验箱, 型号 XR-XZ301 , 尺寸: 50cmx50cmx40cm;  [0188] Rat open field experiment box, model XR-XZ301, size: 50cmx50cmx40cm;
[0189] 大鼠高架十字迷宫 (EPM) , 型号 XR-XG201 , EPM宫体尺寸: 臂宽 10cm, 臂 长 50cm, 臂高 30cm; [0190] Xmaze动物行为分析系统, 型号 XR-Xmaze, 以上仪器均购自上海欣软信息科 技有限公司; [0189] Rat elevated plus maze (EPM), model XR-XG201, EPM palace size: arm width 10cm, arm length 50cm, arm height 30cm; [0190] Xmaze animal behavior analysis system, model XR-Xmaze, the above instruments are all purchased from Shanghai Xinsoft Information Technology Co., Ltd.;
[0191] ST-A数字脉冲生物刺激仪 (济南空军后勤装配总厂和山东中医药大学共同研制  [0191] ST-A Digital Pulse Biostimulator (Jinan Air Force Logistics Assembly Factory and Shandong University of Traditional Chinese Medicine jointly developed)
[0192] 优普超纯水机 (成都超纯科技有限公司) 。 [0192] Youpu ultra-pure water machine (Chengdu Chaochun Technology Co., Ltd.).
[0193] 实验方法 Experimental method
[0194] 动物分组及焦虑大鼠模型制备  [0194] Animal grouping and anxiety rat model preparation
[0195] 大鼠经 1周适应期后进行旷场实验, 选取旷场实验得分相近的 60只大鼠进行实 验, 并随机分为 6组, 每组 10只, 即空白组、 模型组、 DXP组、 HFM (本发明中 药制剂高剂量组) 组、 MFM (本发明中药制剂中剂量组) 组、 LFM (本发明中 药制剂低剂量组) 组。  [0195] The rats were subjected to the open field experiment after 1 week of adaptation, and 60 rats with similar scores in the open field experiment were selected and randomly divided into 6 groups, 10 in each group, namely blank group, model group, DXP. Group, HFM (high-dose group of Chinese medicine preparations of the present invention) group, MFM (dose group of Chinese medicine preparations of the present invention) group, LFM (low-dose group of Chinese medicine preparations of the present invention) group.
[0196] ①空白组: 不接受电击, 正常饲养, 其余各组腹腔注射的同吋给予纯水 2ml/kg/ d腹腔注射。  [0196] 1 blank group: no electric shock was received, normal feeding, and the other groups were intraperitoneally injected with pure water 2 ml/kg/d.
[0197] ②模型组: 利用 ST- A数字脉冲生物刺激仪, 采用足底电击法 (FootShock, FS ) 诱发大鼠焦虑样行为, 具体做法为: 将大鼠置于可调式噪音、 激惹、 脉冲电 刺激笼内, 设定造模条件: 白天 2档 (间隔 5min) , 夜间 3档 (间隔 lOmin) , 电 流 0.5mA, 电压 2700-3300v, 脉宽 0.3s, 刺激吋间共计 12d; 造模的同吋给予纯水 2ml/kg/d腹腔注射。  [0197] 2 model group: Using the ST-A digital pulse biostimulator, the foot-shocking method (FootShock, FS) was used to induce anxiety-like behavior in rats by: placing the rat in adjustable noise, irritating, Pulse electric stimulation cage, set modeling conditions: 2 times in the day (interval 5min), 3 in the night (interval lOmin), current 0.5mA, voltage 2700-3300v, pulse width 0.3s, stimulating the daytime total 12d; The same sputum was given intraperitoneal injection of pure water 2ml/kg/d.
[0198] ③ DXP组: 按②造模, 同吋给予地西泮 lml/kg/d腹腔注射。 [0198] 3 DXP group: According to 2 model, the same dose of diazepam lml / kg / d intraperitoneal injection.
[0199] ④ HFM组: 按②造模, 同吋给予 FM药物, lml/kg/d腹腔注射。 [0199] 4 HFM group: According to 2 modeling, the same FM drugs were given, lml/kg/d intraperitoneal injection.
[0200] ⑤ MFM组: 按②造模, 同吋给予 FM药物, 0.5 lml/kg/d腹腔注射。 [0200] 5 MFM group: According to 2 modeling, FM drugs were given at the same time, 0.5 lml/kg/d was intraperitoneally injected.
[0201] ⑥ LFM组: 按②造模, 同吋给予 FM药物, 0.25 lml/kg/d腹腔注射。 [0201] 6 LFM group: According to 2 model, FM drugs were given at the same time, 0.25 lml/kg/d was intraperitoneally injected.
[0202] 造模完成后即采用旷场实验和 EPM实验对其行为学进行评价。 [0202] After the modeling was completed, the behavior of the behavior was evaluated using the open field experiment and the EPM experiment.
[0203] 统计方法 Statistical method
[0204] 实验数据采用 SPSS 17.0统计软件分析, 采用 GraphPadPrism5.0软件进行统计作 图。 多个样本均数比较用单因素方差分析, 结果以平均数士标准差( ±s)表示, 显著性水平为 P< 0.05。 [0204] The experimental data were analyzed by SPSS 17.0 statistical software, and statistical mapping was performed using GraphPad Prism 5.0 software. Multiple sample means were compared using one-way ANOVA and the results were averaged by ± standard deviation ( ±s) indicates that the significance level is P < 0.05.
[0205] 结果与分析 [0205] Results and analysis
[0206] 各剂量 FM对大鼠旷场实验运动总路径的影响  [0206] Effect of each dose of FM on the total motion path of rat open field experiment
[0207] 旷场实验结果显示, 模型组大鼠旷场运动总路径高于空白组 (P<0.01) , 提示 采用足底电击法 (FootShock, FS) 成功诱发了大鼠焦虑样行为。 用药组中的 DX P组和 MFM组大鼠的旷场运动总路径低于模型组 (P<0.01) , LFM组和 HFM组 与模型组相比, 差异无统计学意义, 提示西药地西泮、 本发明中药制剂中剂量 组均干预有效。  [0207] The results of open field experiments showed that the total path of sacral movement in the model group was higher than that in the blank group (P<0.01), suggesting that the foot-shock (FS) successfully induced anxiety-like behavior in rats. The total sacral movement path of the DX P group and the MFM group in the treatment group was lower than that in the model group (P<0.01). There was no significant difference between the LFM group and the HFM group and the model group, suggesting that the western medicine diazepam The dosage group of the traditional Chinese medicine preparation of the invention is effective for intervention.
[0208] 各剂量 FM对大鼠 EPM实验中 OE<¾、 OT<¾的影响  [0208] Effects of various doses of FM on OE<3⁄4, OT<3⁄4 in rat EPM experiments
[0209] ΕΡΜ实验结果表明, 模型组大鼠的 ΟΕ<7^ΠΟΤ<¾均低于空白组 (Ρ<0.01) , 采用 足底电击法成功诱发了大鼠焦虑样行为; MFM组和 DXP组的 0Ε<7 Π0Τ<¾均高于 模型组 (Ρ<0.01) , 提示西药地西泮和 MFM组均对大鼠的焦虑样行为干预有效 , 而 LFM组和 HFM组与模型组相比, 虽未出现显著性差异, 但呈现升高趋势。 提示西药 DXP和 MFM组均对大鼠的焦虑样行为干预有效。  ΕΡΜExperimental results showed that the ΟΕ<7^ΠΟΤ<3⁄4 of the model group rats were lower than the blank group (Ρ<0.01), and the anxiety-like behavior was successfully induced by the foot-shock method; MFM group and DXP group 0Ε<7 Π0Τ<3⁄4 was higher than the model group (Ρ<0.01), suggesting that both the western medicine diazepam and the MFM group were effective in the anxiety-like behavioral intervention in rats, while the LFM group and the HFM group were compared with the model group. There were no significant differences, but there was an upward trend. It is suggested that the western medicine DXP and MFM groups are effective in the intervention of anxiety-like behavior in rats.
[0210] 各组大鼠行为学比较  [0210] Behavioral comparison of rats in each group
Figure imgf000022_0001
本实验采用足底电击法制备焦虑大鼠模型, 该模型为动物情绪致病模型中的经 典方法, 即把拟造模大鼠置入可调式噪音电刺激笼内, 大鼠足部、 身体在受到 电刺激的同吋伴有噪音刺激, 结合噪音是为了建立条件反射, 在电流变小的情 况下噪音即能达到与之前电击相同的效果。 一可减少电击造成的躯体伤害, 二 可加强心理性应激以此模拟人类情绪上的持久紧张, 设定造模条件: 白天 2档 ( 间隔 5min) , 夜间 3档 (间隔 lOmin) , 中等强度电流 0.5mA, 电压 2700-3300v, 脉宽 0.3s, 持续 12天, 电刺激条件在大鼠可承受范围, 经此方法大鼠出现易激惹 、 精神紧张、 四下乱窜、 跳起等情绪亢奋反应, 这类似于临床上焦虑症患者紧 张、 易激惹等表现。 利用此方法制备焦虑动物模型比较符合疾病的症状表现。
Figure imgf000022_0001
In this experiment, an anastomosis rat model was prepared by the foot-shock method. This model is a classic method in the animal emotional pathogenic model, that is, the modeled rat is placed in an adjustable noise electric stimulation cage, and the rat foot and body are in the body. The electric stimulation is accompanied by noise stimulation, and the noise is combined to establish the conditioned reflection. When the current is small, the noise can achieve the same effect as the previous electric shock. One can reduce the body damage caused by electric shock, Psychological stress can be strengthened to simulate the persistent tension in human emotions. The modeling conditions are set: 2 in the day (5 min interval), 3 in the night (interval lOmin), medium intensity current 0.5 mA, voltage 2700-3300 v, pulse The width is 0.3s, lasts for 12 days, and the electrical stimulation condition can be tolerated in rats. Through this method, the rats have irritating, nervous, squatting, jumping and other emotional hyperactivity reactions, which is similar to clinical anxiety. The patient is nervous, irritating and other manifestations. The preparation of an anxious animal model using this method is more consistent with the symptomatic manifestations of the disease.
[0212] 本研究中模型组大鼠旷场实验总路径较空白组明显升高; 模型组大鼠的 05%和 0T%较空白组明显降低。 表明模型组大鼠处于焦虑状态, 造模成功。 DXP组和 MFM组大鼠总路径较模型组降低, 差异具有高度统计学意义, LFM组、 HFM组 大鼠总路径与模型组相比, 差异无显著性统计学意义, 但呈现降低趋势; DXP 组和 MFM组大鼠的 0Ε<7^Π0Τ%较模型组均提高, 差异具有显著统计学意义, 而 LFM组、 HFM组的 0Ε<7^Π0Τ%与模型组相比仍无显著性差异, 但也呈现升高趋 势。 以上结果表明地西泮和本发明中药制剂中剂量作用浓度具有抗焦虑作用, 本发明中药制剂小剂量 (相当于人临床剂量 4倍) 或高剂量组 (相当于人临床剂 量 16倍) 也呈现抗焦虑作用, 但差异无统计学意义。  [0212] In this study, the total path of the open field test in the model group was significantly higher than that in the blank group; 05% and 0T% in the model group were significantly lower than those in the blank group. It indicated that the rats in the model group were in an anxious state and the model was successful. The total path of rats in DXP group and MFM group was lower than that in model group. The difference was highly statistically significant. The total path of rats in LFM group and HFM group was not statistically significant compared with the model group, but showed a decreasing trend; DXP The 0Ε<7^Π0Τ% of the rats in the group and the MFM group were higher than those in the model group, and the difference was statistically significant. However, there was no significant difference between the 0M<7^Π0Τ% of the LFM group and the HFM group compared with the model group. But it also shows an upward trend. The above results indicate that the dose-dose concentration of diazepam and the traditional Chinese medicine preparation of the present invention has an anxiolytic effect, and the low-dose (equivalent to human clinical dose 4 times) or high-dose group (equivalent to human clinical dose 16 times) of the traditional Chinese medicine preparation also presents Anxiolytic effects, but the difference was not statistically significant.
[0213] 这一结果显示中药复方本发明中药制剂复方剂量与功效的关系并非正相关, 也 从另一方面提示中药的量效关系的确有其自身特点, 不同于西药单纯的量效关 系阐述。 由此可见, 中药复方的量效关系受诸多因素的调控, 临床用药吋要考 虑各个方面因素, 因人制宜, 因地制宜, 在临床实践中不断摸索最精当的药物 剂量, 以获得最佳疗效。 通过以上行为学评价结果证实了本实验成功复制了大 鼠焦虑情绪模型, 足底电击法作为一种焦虑动物造模方法, 稳定有效且重复性 好, 值得推广应用。 本实验同吋也再次证实中药本发明中药制剂和西药地西泮 片均具有抗焦虑作用, 其中本发明中药制剂低、 中、 高剂量组以中剂量组抗焦 虑效果较为明显, 可用其进行后续机制研究。  [0213] This result shows that the relationship between the compound dose and the efficacy of the traditional Chinese medicine compound of the present invention is not positively correlated, and it also suggests that the dose-effect relationship of the traditional Chinese medicine does have its own characteristics, which is different from the simple dose-effect relationship of the western medicine. It can be seen that the dose-effect relationship of traditional Chinese medicine compound is regulated by many factors. The clinical use of drugs should consider various factors, adapt to local conditions, adapt to local conditions, and constantly explore the most precise drug dosage in clinical practice to obtain the best effect. The above behavioral evaluation results confirmed that the experiment successfully replicated the anxiety model of rats. As a method of modeling animal models, the foot-shock method is stable, effective and reproducible, and it is worthy of popularization and application. This experiment also confirmed that the traditional Chinese medicine preparation and the western medicine diazepam tablets have anti-anxiety effects, and the low-, medium-, and high-dose groups of the traditional Chinese medicine preparations have obvious anti-anxiety effects in the middle dose group, and can be used for subsequent follow-up. Mechanism research.
[0214] 所有上述的首要实施这一知识产权, 并没有设定限制其他形式的实施这种新产 品和 /或新方法。 本领域技术人员将利用这一重要信息, 上述内容修改, 以实现 类似的执行情况。 但是, 所有修改或改造基于本发明新产品属于保留的权利。  [0214] All of the above-mentioned primary implementations of this intellectual property do not set limits on other forms of implementation of such new products and/or new methods. Those skilled in the art will utilize this important information and modify the above to achieve a similar implementation. However, all modifications or adaptations based on the present invention are a reserved right.
[0215] 以上所述, 仅是本发明的较佳实施例而已, 并非是对本发明作其它形式的限制 , 任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为 等同变化的等效实施例。 但是凡是未脱离本发明技术方案内容, 依据本发明的 技术实质对以上实施例所作的任何简单修改、 等同变化与改型, 仍属于本发明 技术方案的保护范围。 The above description is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention. Any person skilled in the art may use the above-disclosed technical contents to change or modify it. An equivalent embodiment of equivalent changes. However, any simple modifications, equivalent changes and modifications made to the above embodiments in accordance with the technical spirit of the present invention are still within the scope of protection of the technical solutions of the present invention.

Claims

权利要求书 Claim
[权利要求 1] 一种治疗广泛性焦虑症气血不足证型的中药制剂, 其特征在于: 原料 药包括酸枣仁、 当归、 白芍、 熟地黄、 川芎、 阿胶、 人参、 黄芪、 党 参、 炙甘草、 大枣、 浮小麦、 法半夏、 胆南星、 陈皮、 柴胡、 郁金、 黄花菜、 茯神木、 首乌藤和远志。  [Claim 1] A traditional Chinese medicine preparation for treating a generalized anxiety disorder with qi and blood deficiency syndrome, characterized in that: the raw material medicine includes Suanzaoren, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ginseng, Astragalus, Codonopsis, and Poria Licorice, jujube, floating wheat, French pinellia, gallbladder, orange peel, Bupleurum, turmeric, day lily, 茯神木, Shouwu vine and Yuanzhi.
[权利要求 2] 如权利要求 1所述的治疗广泛性焦虑症气血不足证型的中药制剂, 其 特征在于: 所述中药制剂中各原料药的重量份分别为酸枣仁 25重量份 〜40重量份、 当归 30重量份〜 40重量份、 白芍 25重量份〜 35重量份、 熟地黄 20重量份〜 30重量份、 川芎 20重量份〜 25重量份、 阿胶 25重量 份〜 30重量份、 人参 35重量份〜 40重量份、 黄芪 30重量份〜 45重量份 、 党参 25重量份〜 35重量份、 炙甘草 15重量份〜 25重量份、 大枣 10重 量份〜 25重量份、 浮小麦 10重量份〜 15重量份、 法半夏 15重量份〜 20 重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20重量份、 柴 胡 15重量份〜 25重量份、 郁金 20重量份〜 30重量份、 黄花菜 15重量份 〜20重量份、 茯神木 20重量份〜 25重量份、 首乌藤 20重量份〜 30重量 份和远志 10重量份〜 15重量份。  [Claim 2] The traditional Chinese medicine preparation for treating a generalized anxiety disorder qi and blood deficiency syndrome type according to claim 1, wherein: the weight fraction of each raw material medicine in the traditional Chinese medicine preparation is 25 parts by weight of Suanzaoren~40 30 parts by weight to 40 parts by weight of Angelica sinensis, 25 parts by weight to 35 parts by weight of radix, 20 parts by weight to 30 parts by weight of Rehmannia glutinosa, 20 parts by weight to 25 parts by weight of chuanxiong, and 25 parts by weight to 30 parts by weight of Ejiao. Ginseng 35 parts by weight to 40 parts by weight, Astragalus 30 parts by weight to 45 parts by weight, Codonopsis 25 parts by weight to 35 parts by weight, Zhigancao 15 parts by weight to 25 parts by weight, Jujube 10 parts by weight to 25 parts by weight, floating wheat 10 Parts by weight to 15 parts by weight, 15 parts by weight to 15 parts by weight of Banxia, 10 parts by weight to 15 parts by weight of cucumin, 15 parts by weight to 20 parts by weight of dried tangerine peel, 15 parts by weight to 25 parts by weight of Bupleurum, and turmeric 20 Parts by weight to 30 parts by weight, 15 parts by weight of day lily to 20 parts by weight, 20 parts by weight to 25 parts by weight of sassafras, 20 parts by weight to 30 parts by weight of S. chinensis and 10 parts by weight to 15 parts by weight of Yuanzhi.
[权利要求 3] 如权利要求 1或 2所述的治疗广泛性焦虑症气血不足证型的中药制剂, 其特征在于: 所述中药制剂中各原料药的重量份分别为酸枣仁 30重量 份〜 35重量份、 当归 35重量份〜 40重量份、 白芍 25重量份〜 30重量份 、 熟地黄 25重量份〜 30重量份、 川芎 20重量份〜 25重量份、 阿胶 25重 量份〜 30重量份、 人参 35重量份〜 40重量份、 黄芪 35重量份〜 40重量 份、 党参 30重量份〜 35重量份、 炙甘草 15重量份〜 20重量份、 大枣 15 重量份〜 20重量份、 浮小麦 10重量份〜 15重量份、 法半夏 15重量份〜 20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20重量份、 柴胡 20重量份〜 25重量份、 郁金 20重量份〜 25重量份、 黄花菜 15重量 份〜 20重量份、 茯神木 20重量份〜 25重量份、 首乌藤 25重量份〜 30重 量份和远志 10重量份〜 15重量份。  [Claim 3] The traditional Chinese medicine preparation for treating a generalized anxiety disorder qi and blood deficiency syndrome type according to claim 1 or 2, wherein: the weight fraction of each raw material medicine in the traditional Chinese medicine preparation is 30 parts by weight of Suanzaoren ~35 parts by weight, angelica 35 parts by weight to 40 parts by weight, chalk 25 parts by weight to 30 parts by weight, rehmannia 25 parts by weight to 30 parts by weight, chuanxiong 20 parts by weight to 25 parts by weight, gelatin 25 parts by weight to 30 weight Parts, ginseng 35 parts by weight to 40 parts by weight, astragalus 35 parts by weight to 40 parts by weight, codonopsis 30 parts by weight to 35 parts by weight, licorice 15 parts by weight to 20 parts by weight, jujube 15 parts by weight to 20 parts by weight, float 10 parts by weight to 15 parts by weight of wheat, 15 parts by weight to 20 parts by weight of Banxia, 10 parts by weight to 15 parts by weight of cucumin, 15 parts by weight to 20 parts by weight of dried tangerine peel, 20 parts by weight to 25 parts by weight of Bupleurum, and depressed 20 parts by weight of gold to 25 parts by weight, 15 parts by weight to 20 parts by weight of day lily, 20 parts by weight to 25 parts by weight of sassafras, 25 parts by weight to 30 parts by weight of Shouwu vine and 10 parts by weight to 15 parts by weight of Yuanzhi.
[权利要求 4] 如权利要求 1至 3所述的治疗广泛性焦虑症气血不足证型的中药制剂, 其特征在于: 所述中药制剂中各原料药的重量份分别为酸枣仁 30重量 份、 当归 35重量份、 白芍 30重量份、 熟地黄 25重量份、 川芎 25重量份 、 阿胶 30重量份、 人参 40重量份、 黄芪 40重量份、 党参 30重量份、 炙 甘草 20重量份、 大枣 20重量份、 浮小麦 10重量份、 法半夏 15重量份、 胆南星 10重量份、 陈皮 20重量份、 柴胡 20重量份、 郁金 25重量份、 黄 花菜 15重量份、 茯神木 20重量份、 首乌藤 25重量份和远志 10重量份。 [Claim 4] The traditional Chinese medicine preparation for treating a generalized anxiety disorder syndrome of qi and blood deficiency according to claims 1 to 3, The method comprises the following steps: the weight fraction of each raw material medicine in the traditional Chinese medicine preparation is 30 parts by weight of Suanzaoren, 35 parts by weight of Angelica sinensis, 30 parts by weight of Radix, 25 parts by weight of Rehmannia glutinosa, 25 parts by weight of Chuanxiong, 30 parts by weight of Ejiao, and 40 parts by weight of ginseng, 40 parts by weight of astragalus, 30 parts by weight of Codonopsis pilosula, 20 parts by weight of licorice, 20 parts by weight of jujube, 10 parts by weight of floating wheat, 15 parts by weight of Pinellia, 10 parts by weight of cucumin, 20 parts by weight of dried tangerine peel. 20 parts by weight of Bupleurum, 25 parts by weight of turmeric, 15 parts by weight of day lily, 20 parts by weight of sassafras, 25 parts by weight of Shouwu vine and 10 parts by weight of Yuanzhi.
[权利要求 5] —种治疗广泛性焦虑症气血不足证型的中药注射液, 其特征在于: 原 料药包括酸枣仁、 当归、 白芍、 熟地黄、 川芎、 阿胶、 人参、 黄芪、 党参、 炙甘草、 大枣、 浮小麦、 法半夏、 胆南星、 陈皮、 柴胡、 郁金[Claim 5] A traditional Chinese medicine injection for treating a generalized anxiety disorder with qi and blood deficiency syndrome, characterized in that: the raw material medicine includes Suanzaoren, Angelica, Angelica, Radix Rehmanniae, Rhizoma Chuanxiong, Ejiao, Ginseng, Astragalus, Codonopsis, Licorice, jujube, floating wheat, French pinellia, gallbladder, cinnabar, Bupleurum, turmeric
、 黄花菜、 茯神木、 首乌藤和远志。 , day lily, 茯神木, Shouwu vine and Yuanzhi.
[权利要求 6] 如权利要求 5所述的治疗广泛性焦虑症气血不足证型的中药注射液, 其特征在于: 所述中药注射液中各原料药的重量份分别为酸枣仁 25重 量份〜 40重量份、 当归 30重量份〜 40重量份、 白芍 25重量份〜 35重量 份、 熟地黄 20重量份〜 30重量份、 川芎 20重量份〜 25重量份、 阿胶 25 重量份〜 30重量份、 人参 35重量份〜 40重量份、 黄芪 30重量份〜 45重 量份、 党参 25重量份〜 35重量份、 炙甘草 15重量份〜 25重量份、 大枣 10重量份〜 25重量份、 浮小麦 10重量份〜 15重量份、 法半夏 15重量份 〜20重量份、 胆南星 10重量份〜 15重量份、 陈皮 15重量份〜 20重量份 、 柴胡 15重量份〜 25重量份、 郁金 20重量份〜 30重量份、 黄花菜 15重 量份〜 20重量份、 茯神木 20重量份〜 25重量份、 首乌藤 20重量份〜 30 重量份和远志 10重量份〜 15重量份。  [Claim 6] The traditional Chinese medicine injection for treating a generalized anxiety disorder qi and blood deficiency syndrome according to claim 5, wherein: the weight fraction of each raw material medicine in the traditional Chinese medicine injection solution is 25 parts by weight of Suanzaoren 40 parts by weight, 30 parts by weight of angelica to 40 parts by weight, 25 parts by weight to 35 parts by weight of white peony, 20 parts by weight to 30 parts by weight of Rehmannia glutinosa, 20 parts by weight to 25 parts by weight of chuanxiong, and 25 parts by weight to 30 parts by weight of Ejiao Parts, ginseng 35 parts by weight to 40 parts by weight, astragalus 30 parts by weight to 45 parts by weight, Codonopsis 25 parts by weight to 35 parts by weight, licorice 15 parts by weight to 25 parts by weight, jujube 10 parts by weight to 25 parts by weight, floating 10 parts by weight to 15 parts by weight of wheat, 15 parts by weight to 20 parts by weight of Pinellia, 10 parts by weight to 15 parts by weight of cucumin, 15 parts by weight to 20 parts by weight of dried tangerine peel, 15 parts by weight to 25 parts by weight of Bupleurum, and depressed 20 parts by weight of gold to 30 parts by weight, 15 parts by weight to 20 parts by weight of day lily, 20 parts by weight to 25 parts by weight of sassafras, 20 parts by weight to 30 parts by weight of sage, and 10 parts by weight to 15 parts by weight of Yuanzhi.
[权利要求 7] 权利要求 5或 6所述中药注射液的制备方法, 其特征在于, 包括:  [Claim 7] The method for preparing a traditional Chinese medicine injection according to claim 5 or 6, characterized in that it comprises:
第一步, 将各原料药分别碎成粗粉, 混合在一起, 加入相对于混合物 质量 1〜2倍的醇浓度为 80%的乙醇, 润湿 12小吋, 随后装柱进行渗漉 , 渗漉液为醇浓度为 80%的乙醇, 使用的乙醇量为混合物质量的 15〜 20倍, 渗漉速度 5ml.min - '.kg - ', 收集渗漉液, 减压浓缩至 65°C吋相 对密度为 1.25〜1.30的浸膏;  In the first step, the raw materials are crushed into coarse powders, mixed together, and ethanol having an alcohol concentration of 80% relative to the mass of the mixture is added, and the mixture is wetted for 12 hours, followed by packing for percolation and infiltration. The mash is ethanol with an alcohol concentration of 80%. The amount of ethanol used is 15 to 20 times the mass of the mixture, and the percolation rate is 5 ml.min - '.kg - '. The percolate is collected and concentrated under reduced pressure to 65 ° C. An extract having a relative density of 1.25 to 1.30;
第二步, 将第一步获得浸膏按照 1: 1的体积比加入醇浓度为 80%的乙 醇, 2〜5°C冷藏静置 24〜48小吋, 过滤除掉沉淀; 滤液减压回收, 获 得干膏, 粉碎成粉末, 加注射用水至所需制剂体积的 80%, 加入注射 级活性炭, 加热至微沸并保持 10〜30分钟搅拌, 过滤除掉活性炭, 加 注射用水至所需制剂体积的 100%; 次经 0.22μηι的滤膜过滤, 调节滤 液温度至 30°C〜50°C, 用截留分子量 8000〜30000的超滤膜, 在压力 为 0.05〜0.3MPa下进行超滤, 超滤液经灌封、 灭菌、 包装。 In the second step, the first step of obtaining the extract is added to the alcohol having an alcohol concentration of 80% in a volume ratio of 1:1. Alcohol, 2~5°C, let stand for 24~48 hours, remove the precipitate by filtration; recover the filtrate under reduced pressure, obtain dry paste, pulverize into powder, add water for injection to 80% of the required preparation volume, add injection grade activated carbon Heat to a slight boiling and keep stirring for 10~30 minutes, remove the activated carbon by filtration, add water for injection to 100% of the required volume of the preparation; filter through the filter of 0.22μηι, adjust the temperature of the filtrate to 30 °C~50 °C Ultrafiltration is carried out at a pressure of 0.05 to 0.3 MPa using an ultrafiltration membrane having a molecular weight cut off of 8,000 to 30,000, and the ultrafiltrate is potted, sterilized, and packaged.
PCT/CN2016/106765 2016-03-07 2016-11-22 Traditional chinese medicine preparation for treating qi and blood deficiency-type generalized anxiety disorder WO2017152655A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610127809.X 2016-03-07
CN201610127809.XA CN105664051A (en) 2016-03-07 2016-03-07 Traditional Chinese medicine preparation for treating qi-blood deficiency of generalized anxiety disorder

Publications (1)

Publication Number Publication Date
WO2017152655A1 true WO2017152655A1 (en) 2017-09-14

Family

ID=56306984

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/106765 WO2017152655A1 (en) 2016-03-07 2016-11-22 Traditional chinese medicine preparation for treating qi and blood deficiency-type generalized anxiety disorder

Country Status (2)

Country Link
CN (1) CN105664051A (en)
WO (1) WO2017152655A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105664051A (en) * 2016-03-07 2016-06-15 王平平 Traditional Chinese medicine preparation for treating qi-blood deficiency of generalized anxiety disorder
CN105920431A (en) * 2016-07-15 2016-09-07 青岛市市立医院 Traditional Chinese medicinal preparation for treating postpartum qi and blood deficiency induced depression
CN111346005A (en) * 2020-05-19 2020-06-30 辽宁中医药大学 Lithium battery moxibustion bracelet capable of soothing nerves and helping sleep

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015654A (en) * 2007-03-07 2007-08-15 中国人民解放军第三医院 Oral traditional Chinese medicine preparation for treating depression and dysphoria
CN101244208A (en) * 2008-03-25 2008-08-20 中国人民解放军第三医院 Method of preparing traditional Chinese medicine preparation for treating melancholia and anxiety neurosis
CN101496865A (en) * 2009-03-19 2009-08-05 杨颖� Chinese medicament preparation for treating depression and anxiety as well as preparation method thereof
CN105664051A (en) * 2016-03-07 2016-06-15 王平平 Traditional Chinese medicine preparation for treating qi-blood deficiency of generalized anxiety disorder

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015654A (en) * 2007-03-07 2007-08-15 中国人民解放军第三医院 Oral traditional Chinese medicine preparation for treating depression and dysphoria
CN101244208A (en) * 2008-03-25 2008-08-20 中国人民解放军第三医院 Method of preparing traditional Chinese medicine preparation for treating melancholia and anxiety neurosis
CN101496865A (en) * 2009-03-19 2009-08-05 杨颖� Chinese medicament preparation for treating depression and anxiety as well as preparation method thereof
CN105664051A (en) * 2016-03-07 2016-06-15 王平平 Traditional Chinese medicine preparation for treating qi-blood deficiency of generalized anxiety disorder

Also Published As

Publication number Publication date
CN105664051A (en) 2016-06-15

Similar Documents

Publication Publication Date Title
CN101757528A (en) Traditional Chinese medicine composition for treating symptoms of deficiency of kidney yin and soreness and weakness of waist and knees and preparation method thereof
CN105663607A (en) Traditional Chinese medicine composition as well as preparation method and application thereof
CN103520618A (en) Preparation method of okra plant viagra
CN102580000B (en) Medicament for curing cancer pain and preparation method thereof
WO2017152655A1 (en) Traditional chinese medicine preparation for treating qi and blood deficiency-type generalized anxiety disorder
CN104983985B (en) A kind of Chinese medicine preparation of Cure of depression
CN102462825B (en) Compound traditional Chinese medicine for treating depression
CN105535495A (en) Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method
CN104667199A (en) Pharmaceutical preparation for treating mental anxiety and application of pharmaceutical preparation
CN104383421A (en) Pharmaceutical preparation for treating insomnia and dreaminess
CN104383420A (en) Preparation method of pharmaceutical preparation for treating insomnia and dreaminess
CN101195003B (en) Proprietary Chinese medicine for treating apoplexy and sequela
CN101194982B (en) Antidepressive Chinese medicine composition and method of preparing the same
CN114224998A (en) Traditional Chinese medicine composition for treating spleen-kidney yang deficiency type functional dyspepsia, preparation and application
CN106310133A (en) Traditional Chinese medicine and medicine pillow for treating depression, resisting anxiety, resisting insomnia and relieving senile dementia
CN104352994A (en) Pharmaceutical preparation for sexual dysfunction
CN107137504B (en) Health food for improving sleep and enhancing immunity
CN104547642A (en) Tradtional Chinese medicine composition for treating female fibromyalgia syndromes
CN104491677A (en) Preparation method of medicament for treating sexual dysfunction
CN105055694B (en) A kind of Chinese medicine preparation for the treatment of fire derived from stagnation of liver-QI type depression
CN116688058B (en) Li medicine for impotence, preparation method and application thereof
CN104435437B (en) A kind ofly treat Chinese medicine of the concurrent glossopharyngeal neuralgia of trigeminal neuralgia and preparation method thereof
CN104206597B (en) A kind of schisandra health care tea alleviating YIN-deficiency of the lung and kidney symptom and preparation method thereof
CN102872292A (en) Traditional Chinese medicine for curing spleen and kidney deficiency type ischemic post-stroke depression
CN102441103A (en) Medicine for treating insomnia

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16893298

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 16893298

Country of ref document: EP

Kind code of ref document: A1